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Microorganisms, the unseen majority, play an important role in environmental
and human health. Globally there are an estimated 4 to 6×1030 prokaryotic cells on
earth driving processes such as the carbon and nitrogen cycle [104, 46, 104]. In the
human body, bacterial cells are as abundant as human cells [90] and aid in funda-
mental processes such as digestion [23, 111]. The human gut microbiome has been
linked to numerous diseases ranging from inflammatory bowel disease to autism [23,
94]. Biotherapeutics, probiotics developed to treat disease, have the potential to rev-
olutionize medicine and treat microbiome-linked diseases [111]. For example, fecal
microbiome transplants have been successfully used to treat recalcitrant Clostridium
dificile infections [81]. Accurately characterizating microbial communities is critical
to successful biotherapeutics development.
Recent advances in deoxyribonucleic acid (DNA) sequencing technology has
changed how we measure and thus study, microbiomes. The two most commonly
used methods to characterize microbial communities are shotgun metagenomics and
16S ribosomal ribonucleic acid (rRNA) marker-gene surveys [52]. Shotgun metage-
nomics is the random sequencing of all genomic material in a sample. 16S rRNA
2
marker-gene surveys use targeted sequencing to characterize community taxonomic
composition. There are benefits and disadvantage to both methods [25]. Shotgun
sequencing is useful for functional information and strain-level analysis, whereas
marker-gene sequencing provides a more complete view of the community composi-
tion. Additionally, shotgun sequencing is significantly more expensive than marker-
gene surveys and is, therefore, cost prohibitive for large cohort and global studies,
such as the human microbiome project [99] and earth microbiome project [98]. The
focus of this dissertation is assessing 16S rRNA marker-gene survey methods. How-
ever, the approaches presented apply to shotgun metagenomic method assessment
as well.
1.1 16S rRNA Marker-Gene Surveys
Marker-gene survey data is used to characterize both organismal and commu-
nity level differences [34]. Differential abundance testing is a type of organismal
level analysis used to identify organisms associated with specific treatment condi-
tions, for example, a pathogen associated with a disease state. Ecological diversity
metrics are used to characterize microbial community richness and evenness within
individual samples (alpha-diversity) and sample pairwise similarity (beta-diversity).
Marker-gene survey data is collected through a complex multi-step measure-
ment process [34]. The measurement process consists of numerous laboratory and
computational steps. Laboratory steps include DNA extraction, polymerase chain
reaction (PCR), library preparation, and sequencing. Computational steps include
3
pre-processing, feature inference, feature annotation, and normalization. See Sec-
tions 2.1 and 2.2 for a detailed description of the measurement processes. Limita-
tions in our understanding of the measurement process impede microbiome research.
1.2 Measurement Assessment
Measurement assessment is used to characterize and validate the measurement
process and as a result, advance microbiome research. Results from marker-gene
surveys indicate a potential connection between obesity and the gut microbiome
[54]. However, a meta-analysis combining data from multiple studies only found
a weak association between obesity and the gut microbiome [95]. With a well-
characterized measurement process, we can better evaluate study conclusions. In
turn, reducing the identification of spurious associations, such as the ones identified
by the obesity studies analyzed in the Sze and Schloss [95] meta-analysis.
A key component of measurement assessment is data with an expected value.
Common sources of data used to assess marker-gene surveys include computer sim-
ulated data (in silco), mixtures of DNA or cells from individual organisms (mock
communities), and technical replicates of environmental samples. In silico data and
mock communities provide expected values for use in assessment but do not recapit-
ulate the complexity of environmental samples or the error profile of real sequencing
data. Without an expected value, technical replicates are only suitable for method
comparison. Another data type, mixtures of environmental samples, provide the
complexity of real data and an expected value for assessment.
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1.3 Dissertation Summary
In this dissertation, I will present a framework for 16S rRNA marker-gene
survey measurement assessment using a novel mixture dataset along with software
to facilitate working with 16S rRNA marker-gene survey data. Chapter 2 provides
an overview of the 16S rRNA sequencing measurement process and assessment. In
Chapter 3, I describe the development and application of an assessment framework
for evaluate the relative and differential abundance values for count tables gener-
ated using different bioinformatic pipelines. For Chapter 4, I developed methods
to assess beta-diversity. I then used the methods to evaluate the impact of se-
quencing artifacts on bioinformatic pipelines and normalization methods. Chapters
3 and 4 utilize a two-sample titration assessment dataset generated are part of this
disseration (Fig. 1.1). Finally, Chapter 5 describes the Bioconductor R package,
metagenomeFeatures, I developed for working with 16S rRNA marker-gene survey
data and 16S rRNA databases. The assessment framework and software along with
the assessment study results presented here will facilitate the development of im-
proved computational methods and advance our understanding of the marker-gene
survey measurement process. The last three sections of this chapter provide a brief
overview of the three main disseration chapters.
1.3.1 Abundance Assessment
The proper measurement method evaluation characterizes the impact of indi-
vidual steps on the measurement process. Furthermore, it also helps identify where
5
Figure 1.1: Assessment dataset experimental design flowchart. Two-sample titra-
tion series were generated using DNA from stool samples collected as part of
an Enterotoxigenic Escherichia coli (ETEC) vaccine trial. The titration end
point samples were selected as the initial sampling timepoint in the vaccine trial
and timepoint after exposure with the highest measured concentration of ETEC.
The assessment dataset includes multiple biological factors and technical repli-
cates enabling the charaterization of multiple sources of bias and dispersion in the
measurement process.The assessment dataset includes samples from five subjects,
vaccine trial participants, with a two-sample titration series for each subject. Four
16S rRNA PCR replicates per titration series sample. The PCR assays were split
into technical replicates and sent to two laboratories for library preparation and
sequencing. Libraries were sequenced twice as each laboratory for a total of four
sequence datasets.
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to focus efforts for improving the measurement process. Appropriate datasets and
methods are needed to evaluate the 16S rRNA marker-gene-survey measurement
process. Numerous studies have qualitatively and quantitatively assessed the 16S
rRNA measurement process using mock communities, simulated data, and environ-
mental samples.
Qualitative characterisitcs are commonly assessed using mock communities
[10]. As the number of organisms in the mock community is known, the total number
of features can be compared to the expected value. The number of observed features
in a mock community is often significantly higher than the expected number of
organisms [50]. Although, when mock community data are processed using sequence
inference methods the count tables, the observed and expected number of features
is consistent [19]. The higher than expected number of features is often attributed
to sequencing and PCR artifacts as well as reagent contaminants [14, 42]. However,
benchmarking studies evaluating sequence inference methods, such as DADA2, aim
to reduce the number of features due to sequence artifacts. While mock communities
have a known value, they lack the feature diversity and relative abundance dynamic
range of real samples [10].
The quantitative characteristics of 16S rRNA sequence data are normally as-
sessed using mock communities and simulated data. To assess the quantitative accu-
racy of relative abundance estimates, mock communities of equimolar and staggered
concentration are commonly used [50]. Results from relative abundance estimates
using mock communities generated from mixtures of DNA have shown taxonomic
specific effects where individual taxa are under or over represented in a sample.
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These taxonomic specific effects have been attributed to primer mismatches and
DNA extraction biases [14]. Simulated count tables have been used to assess dif-
ferential abundance methods, where specific taxa are artificially overrepresented in
one set of samples compared to another [62]. Only computational steps of the mea-
surement process can be assessed using simulated data.
Quantitative and qualitative assessment can also be performed using sequence
data generated from mixtures of environmental samples. Using simulated data and
mock communities, evaluating and benchmarking new methods can result in over
training the bioinformatic pipelines to data that do not recapitulate the sequencing
error profile and feature diversity of real samples. Data from environmental samples,
which are real samples, are often used to benchmark new molecular laboratory
and computational methods. However, without an expected value with which to
compare, only measurement precision can be evaluated. By mixing environmental
samples, an expected value can be calculated using information from the unmixed
samples and the mixture design. Mixtures of environmental samples have previously
been used to evaluate gene expression measurements, e.g. microarrays and RNAseq
data [71, 76, 97].
In Chapter 3, we describe the mixture dataset of extracted DNA from hu-
man stool samples we generated for assessing 16S rRNA sequencing. The mix-
ture datasets were processed using three bioinformatic pipelines. Using the mix-
ture dataset, we developed novel methods to assess the qualitative and quantitative
characteristics of the pipeline results. The quantitative results were similar across
pipelines but the qualitative results varied by pipelines.
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1.3.2 Diversity Assessment
Biases introduced during the marker-gene survey measurement process can
impact downstream analyses such as beta-diversity. Bioinformatic pipelines and
normalization methods are often used to reduce biases introduced during the marker-
gene survey measurement process [34, 49].
Bioinformatic pipelines reduce bias by removing sequencing artifacts, such
as single and multi-base pair variants, and chimeric sequences, from microbiome
datasets. If not accounted for, these artifacts may incorrectly be attributed to novel
diversity in a sample. Bioinformatic pipelines use clustering or sequence inference
techniques to group reads into biologically informative units. Standard clustering
methods include de novo clustering of sequences based on pairwise sequence sim-
ilarities [88] and closed-reference clustering of reads against a reference database
[29]. Open-reference clustering is a combination of the two, first applying a closed-
reference approach, followed by de novo clustering of reads that did not map to a
reference [82]. Sequence inference methods use statistical models and algorithms to
group sequences independent of similarity, but based on the probability that a lower
abundant sequence is an artifact originating from a more highly abundant sequence
[19, 1]. The resulting features, operational taxonomic units (OTUs) for clustering
methods, and sequence variants (SVs) for sequence inference methods, have different
characteristics because the methods vary in their ability to detect and remove errors
while retaining true biological sequences.
Rarefaction and numeric normalization methods account for differences in sam-
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ple total abundance caused by uneven sample pooling prior to sequencing and dif-
ferences in sequencing run throughput. Rarifying abundance data traces its origins
to macroecology, where counts for a unit (sample) are randomly subsampled to
a user-defined constant level [35]. Although there are concerns about its statis-
tical validity [62], rarefaction is currently the only normalization method for un-
weighted, presence-absence based, beta-diversity metrics [102]. For weighted, abun-
dance based, beta-diversity analyses, we can apply numeric normalization methods,
such as total and cumulative sum scaling (TSS and CSS), where counts are di-
vided by sample total abundance (TSS) or by the cumulative abundance (CSS) for
a defined percentile [72]. CSS is one of the few normalization methods developed
specifically for 16S rRNA marker-gene survey data. Other normalization methods,
including upper quartile (UQ), trimmed mean of M values (TMM) and relative log
expression [84, 58], were initially developed for normalizing RNAseq and microarray
data. Many studies have found these methods useful in normalizing marker-gene
survey data for differential abundance analysis, though it is unclear whether these
techniques are also suitable for beta-diversity analysis.
Beta-diversity is calculated using a variety of metrics that can be grouped
based on whether they account for phylogenetic distance or not and feature relative
abundance or presence/absence. The UniFrac metric was developed for marker-gene
survey data and incorporates phylogenetic relatedness by comparing the branch
lengths of features that are unique to two communities [37]. Unweighted UniFrac
uses presence-absence information, whereas weighted UniFrac incorporates feature
relative abundance. Taxonomic metrics do not consider the relationship between fea-
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tures. The Bray-Curtis and Jaccard dissimilarity indices are examples of weighted
and unweighted taxonomic metrics respectively, as they do not consider the phylo-
genetic relationship between features [13, 44]. These four groups of beta-diversity
metrics measure different community characteristics. The metrics should therefore
be evaluated in a complementary manner to gain maximal insight into community-
level sample differences [2].
Previous studies have evaluated different bioinformatics pipelines [92] and nor-
malization methods [62, 102] using beta-diversity metrics. Yet, how well pipelines
account for low sequence quality and total abundance differences remains unknown.
The mixture dataset includes multiple levels of technical replication, allowing us to
evaluate (1) beta-diversity repeatability, (2) ability to distinguish between groups
of samples with varying similarity, and (3) identify differences in beta-diversity be-
tween biological and technical factors. Furthermore, the dataset includes data from
four sequencing runs with different sequencing error rates and library sizes, enabling
assessment of how each pipeline and method performs on varying quality datasets.
1.3.3 metagenomeFeatures
A key step in 16S rRNA marker-gene survey measurement process is compar-
ing representative sequences to a reference database for taxonomic classification or
phylogenetic placement [65]. There are numerous 16S rRNA reference databases,
of which Greengenes, Ribosomal Database Project (RDP), and SILVA are arguably
the most commonly used [28, 26, 79, 59]. Additionally, there are smaller system-
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specific databases such as the Human Oral Microbiome Database (HOMD) for the
human oral microbiome [22, http://www.homd.org/] and soil reference database
[24]. System-specific databases can improve taxonomic assignments for microbial
communities not well represented in the major databases [85].
16S rRNA databases differ in sequence number and diversity, the taxonomic
classification system, and the inclusion of intermediate ranks [5]. Databases for-
mat their data differently and use sequence identification systems unique to their
database, challenging membership and composition comparisons. For example,
Yang, Wang, and Qian [110] used the SILVA database to evaluate impact of different
16S rRNA variable regions on phylogenetic analysis. Similarly, Martinez-Porchas et
al. [57] evaluated sequence similarity between 16S rRNA gene conserved regions also
using the SILVA database. Differences in database formatting present a significant
barrier to performing the same analysis using multiple databases. Additionally,
taxonomic assignments can be database-dependent, providing further justification
for database comparisons [75]. To facilitate database comparisons RNACentral a
resource combining non-coding RNA databases provides a set of cross database se-
quence identifiers [96, http://rnacentral.org/].
We developed the Bioconductor R package metagenomeFeatures for work-
ing with both 16S rRNA gene databases and marker-gene survey feature data.
metagenomeFeatures provides a common data structure for working with 16S rRNA
databases and marker-gene survey feature data. Additionally, this package is the
first step towards the development of a common data structure for use in analyzing
metagenomic and marker-gene survey data using R Bioconductor packages such as
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phyloseq [60] and metagenomeSeq [73].
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CHAPTER 2
Measurement Process and Assessment.
Metrology, measurement science, provides a well established framework for
validating, characterizing and evaluating measurements [55, 33]. This framework
was established for routine single measurand assays with well defined applications.
Measurement validation is used to determine if a measurement process meets a set
of specific requirement. The measurement process requirements can include mea-
surement bias and precision are within a defined range or a minimum detectable
analyte concentration. For example, measurement validation is used to determine
if an assay is able to detect a specific pathogen in a stool sample at a minimum
concentration. Measurement validation also requires that the sample used to vali-
date the measurement is representative of the sample type the measurement process
will encounter. The samples used for validation must also have known charateristics
for use in evaluating measurement results. As part of the measurement validation
process measurement expanded uncertainty is quantified determined. Measurement
expanded uncertainty is obtained by first defining the measurand, decomposing the
measurement process, and identifying sources of uncertainty [33]. Each source of
uncertainty is quantified by experimental estimation, modelling from theoretical
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principles, or estimation using expert judgement. The expanded uncertainty is cal-
culated by combining uncertainty estimates for individual sources. The observed
measurement value and its expanded uncertainty along with the measurement re-
quirements are used to validate the measurement process.
With 16S rRNA sequencing measurements are made for hundereds to thou-
sands of organisms simultaneously. Furthermore, there is no clear single application
as the same data are used to test multiple hypothesis. The traditional framework for
characterizing and evaluating a measurement process is not easily applied. There-
fore, I present a more general characterization of the measurement method perfor-
mance as measurement assessment, which borrows from the measurement validation
process. Where a measurement process is assessed relative to the measurand, the
entity quantified by the measurement process [9]. Measurement process assessment
consists of three steps; decomposing the measurement process, designing experi-
ments to isolate measurement process elements, and evaluating bias and dispersion
at each element. In this chapter I will describe and decompose the 16S rRNA
sequencing measurement process. After decomposing the measurement process I
will describe common 16S rRNA measurands including feature abundance, relative
abundance, as well as alpha- and beta-diversity. Next, I will describe steps for con-
ducting an assessment experment to characterize measurement process elements.
Finally, I will place the assessment work presented in this dissertation within the


















Figure 2.1: Cause-effect diagram for the 16S rRNA sequencing measurement pro-
cess. Causes of bias and variability are indicated as branches, e.g., cell type, and
different sources of error are indicated by branch labels, e.g., storage conditions.
2.1 Measurement Process
The 16S rRNA marker-gene survey measurement process includes a number
of laboratory and computational steps (Fig. 2.2 and 2.3). In this section, I will
provide an overview of the measurement process, and highlight significant known
sources of error and dispersion (Fig. 2.1). See Goodrich et al. [34] for a review of
16S rRNA marker-gene survey measurement process and general recommendations
for conducting microbiome experiments.
The 16S rRNA gene is used for marker-gene surveys as it is found in all
prokaryotic organisms, including both bacteria and archaea and contains hyper-
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variable and conserved regions. The conserved regions allow for the use of PCR
primers which can amplify the 16S rRNA gene from diverse taxonomic groups [57,
48]. Whereas hypervariable regions, allow genus and sometime species-level taxo-
nomic classification. Additionally, as the 16S rRNA gene is well studied there are
several extensive well-curated databases, e.g. SILVA, RDP, and Greengenes [79, 59,
26]. There are drawbacks to using the 16S rRNA gene as well. Due to the conserved
nature of the gene, sequences cannot be used for the strain-level taxonomic classifi-
cation required for some applications, such as pathogen detection and identification
[45]. Additionally, 16S rRNA is a multicopy gene that is known to be horizontally
transferred between organisms, as a result, the within-genome 16S rRNA gene copy
diversity can be greater than the between-genome diversity for some genera [74].
For the measurement process, laboratory component raw sequence data are
generated from environmental samples (Fig. 2.2). Samples are initially collected
and stored to minimize changes to the community composition prior to sample
processing. Next, DNA is extracted from the sample, and the 16S rRNA is am-
plified using PCR. Then PCR products concentrations are normalized, diluted to
a standard concentration, to minimize between sample variability in the number
of reads obtained per sample. Finally, the normalized PCR products are pooled
and sequenced. Preferential DNA extraction and PCR amplification are two of the
largest sources of bias in the measurement process (Fig. 2.1). Other sources of error
introduced at this point include PCR artifacts such as amplification errors (point
mutations) and chimeras, sequence contaminants, and sequencing errors. Compu-
tational methods correct for PCR artifacts, contaminant removal, and sequencing
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Figure 2.2: Diagram of the 16S rRNA marker gene survey measurement process
for a simplified example study comparing case and control treatment groups.
Samples are first collected from study participants. Colored boxes contains the
true microbial community composition indicated by cartoon cells. The different
cell walls and 16S rRNA sequence (grey oval with colored bar) indicate distinct
biologically relevant units. Next, DNA is isolated from the other cellular material.
Extraction efficiency differences are indicated by differences in the number of red,
yellow, and blue bars relative to the sample numbers. PCR is used to target
the 16S rRNA gene. Amplification efficiency biases shown as differences in the
proportion of red, yellow, and blue PCR products from the DNA extract. Unique
sample barcodes added during PCR are indicated as teal and orange bars on PCR
amplicons. Chimeras, a PCR artifact, are shown as half blue and yellow PCR
products. Sequencing libraries are produced by Pooling PCR products from
the two samples. Uneven pooling can result in the under-representation of a
sample (teal in this example) in the sequence dataset. The resulting libraries are
sequenced, sequencing artifacts are indicated as grey reads, for failed sequences,
and grey vertical lines for single base sequencing errors.
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Figure 2.3: Diagram of the 16S rRNA marker gene survey measurement process
computational steps. Pre-processing assigns sequencing reads to samples using
the unique barcodes and removes low-quality reads as well as filters chimeras.
Feature inference is used to group the pre-processed reads into biologically rel-
evant units. Sequencing errors can result in spurious features if not assigned to
the source feature. The yellow and blue sequences with a grey vertical line are
spurious features. Finally, taxonomic assignment is performed as part of feature
annotation. Spurious features can be assigned to the wrong organism, yellow bar
with grey line, or be unassigned, blue bar with grey line.
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error correction. Currently, there are no computational or laboratory methods to
correct for preferential extraction or amplification.
Computational methods, collectively referred to as the bioinformatic pipeline,
convert raw sequence data into an annotated count table for use in downstream
analysis (Fig. 2.2). Bioinformatic pipelines use the same general approach, though
the methods and order of individual steps vary by pipeline. The first step is
pre-processing the raw reads. Pre-processing includes initial quality control steps,
preparing reads for feature inference. Next, feature inference is performed, grouping
pre-processed into biologically relevant units. Finally, feature annotation is used to
obtain information about feature taxonomy and phylogenetic relatedness. Biases
introduced by the computational methods are either due to failure to correct for
biases from the laboratory component or errors in feature annotation.
The annotated count table is then used in feature-level and community-level
downstream analysis (Fig. 2.4). Differential abundance is the most commonly
used feature-level analysis. Differential abundance is used to estimate feature rel-
ative abundance between treatments [72]. Alpha- and beta-diversity analyses are
the most commonly used type of community analyses. Alpha-diversity metrics are
numeric summaries of individual samples, including richness, evenness, and phylo-
genetic diversity metrics. Beta-diversity is a measure of sample similarity and is
used to compare feature presence-absence or incorporate relative abundance and
phylogenetic relatedness.
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Figure 2.4: Diagram of 16S rRNA marker gene survey differential abundance and
biological diversity downstream analysis methods. Differential abundance is a
row-wise operation comparing feature abundance between treatment conditions
with log fold-change (logFC) estimates calculated for each feature. Alpha (α)
diversity is a column-wise operation where a single value is calculated per sam-
ple. Beta (β) diversity is a row- and column-wise operation, with a single value
calculated for each sample pair, using paired feature information.
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2.2 Feature Inference and Normalization
The following section provides additional details about the feature inference
and computational normalization methods that are the focus of the assessment
framework presented in this disseration. Feature inference is used to group sequences
into features that are representative of biologically relevant units. Computational
normalization is used to reduce biases in downstream analysis due to differences in
total abundance between samples. The feature inference process should maximize
the number of features representing true sequences while minimizing the number of
features representing sequence artifacts. The two primary feature inference method
types are distance-based clustering and sequence inference.
Distance-based feature inference methods cluster sequences based on defined
similarity thresholds. These clustering thresholds are based on taxonomic group
sequence diversity and sequencing error (e.g., 99% species level, 97% genus level,
1% error rate). Though studies characterizing within species and genera 16S rRNA
sequence diversity [74], and sequencing error rates [42, 86, 27] challenge the validity
of these values [31].
There are three approaches to distance-based clustering, de novo, closed-
reference, and open-reference. For de novo clustering, the pre-processed sequences
are clustered based on the desired threshold. For closed-reference clustering, the se-
quences are assigned to reference sequences based on the defined similarity thresh-
old. The reference sequences are sequences from a reference database previously
clustered at the desired threshold. Open-reference clustering combines de novo and
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closed-reference clustering. Reads are first clustered using closed-reference cluster-
ing then reads not assigned to reference clusters are clustered de novo. A limitation
of distance-based feature inference methods is the use of a defined similarity thresh-
old. Sequence inference methods were developed to avoid having to define such
thresholds.
Sequence inference methods, another type of features inference, use statistical
models or heuristic algorithms to infer the true biological sequence from which a
read was generated. By inferring the true biological sequence, this method avoids
having to define an arbitrary threshold for grouping sequences. DADA2, a sequence
inference method, uses a probabilistic model and an expectation-maximization al-
gorithm to test whether less abundant sequences are derived from higher abundance
sequences [19]. DADA2 is the only sequence inference method to consider base
quality scores. DADA2 is computationally expensive on a per sample basis, though
scalable as individual samples can be run in parallel. Other sequence inference meth-
ods use heuristics, reducing the method the computational cost. Similar to DADA2,
UNOISE2 uses a model to assign lower abundance sequences to higher abundance
sequences [30]. However, UNOISE2 uses a single function with parameter values
set using training data. UNOISE2 significantly reduces the computational cost by
using model parameters defined a priori, eliminating the need for the expectation-
maximization step. Deblur proportionally assigns lower abundance sequences to
higher abundance sequences using estimates for the number of lower abundance
sequences that are error derived sequences [1].
After feature inference, the resulting count tables are normalized prior to use
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in downstream analysis. Count table mormalization methods minimize biases due
to differences in the total feature abundance between samples. Variability in to-
tal feature abundance is due to differences in the number of reads generated per
sample, and the proportion of sequences passing quality filtering. There are two
types of normalization methods rarefaction and scaling. Rarefaction has its roots
in ecology, where it is used to normalize sampling intensity per survey area [35, 40].
To rarify counts, individual sample counts are randomly subsampled, without re-
placement, to a user-defined level and samples with total abundance values less than
the rarefaction level are dropped. Scaling methods normalize count table values by
sample-specific normalization factors. For total sum scaling (TSS), and cumulative
sum scaling (CSS), sample counts are divided by the sum of feature counts to a de-
fined abundance percentile, 0.75 for CSS, and total abundance for TSS (proportions)
[72]. Other commonly used normalization methods include relative log expression
(RLE), trimmed mean of M values (TMM), and upper quartile normalization [84,
58]. These methods were developed for normalizing microarray and RNAseq data
but have been successfully used to normalize 16S rRNA marker-gene survey data
[62].
2.3 Conducting an Assessment Experiment
Measurement assessment experiment are used to characterize the bias and dis-
persion for elements of a measurement process. There are four steps to designing a
measurement assessment experiment; (1) define the measurand, (2) identify appro-
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priate data and metrics for the assessment, (3) design an experiment to isolating
element(s) of a measurement process for assessment.
First define the measurand when developing an assessment method. The mea-
surand is the observed value being quantified [9]. For marker-gene survey analysis,
there are multiple measurand definitions. The measurand can be defined based on
the downstream analysis, e.g., log fold-change for differential abundance analysis or
diversity metric for alpha- and beta-diversity analysis. The measurands can also be
more general, such as count table abundance values or feature DNA sequence.
After defining the measurand appropriate data and metrics are identified. The
primary data types used in marker-gene survey measurement assessment include
in-silico data, mock communities, and technical replicates. Different parts of the
measurement process and measurands can be assessed with different data types.
in-silico data, either simulated sequence data or count tables, can be used to as-
sess computational methods and downstream analysis. Mock communities, either
mixtures of DNA or cells, can be used to assess laboratory procedures, as well as
computational methods. Technical replicates are used to assess laboratory and com-
putational method repeatability. Once the measurand is defined, and appropriate
data for assessment is identified, assessment is performed by comparing expected
values to observed values.
Metrics used for assessment are dependent on the statistical properties of the
measurand. For quantitative measurands, such as count table values, relative er-
ror (the difference between the expected and observed values, normalized by the
expected value) is commonly used. For evaluating the linear relationship between
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observed and expected values a linear model can be used to estimate the overall
agreement, R2, and whether the relationship is 1-to-1, model slope. Another metric
for quantitative measurands, is signal-to-noise ratio, for example, with beta-diversity
metrics, the ratio of beta-diversity between and within treatments or conditions. For
qualitative measures, such as feature presence-absence, standard truth table met-
rics, such as sensitivity and specificity can be used. Similarly, area under the curve
(AUC) and receiver operating characteristics (ROC) curves can be used to evaluate
qualitative performance for a set of observed values.
The next step is to determine measurement process steps or element one is in-
terested in evaluating and design an experiment isolating the element. Assessments
can compare the performance of different methods used in individual steps of the
measurement process, for example, DNA extraction or PCR. Assessment methods
can also evalute part of the measurement process, such as the computational or
laboratory components. Alternatively, one can assess the measurement process as
a whole. The part of the measurement process being evaluated defines the experi-
mental design used to generate the assessment dataset.
2.3.1 Assessment using Mixtures of Environmental Samples
Limitations to using environmental samples and mock communities for mea-
surement assessment can be addressed using mixtures of environmental samples.
Mixtures of environmental samples provide the complexity of real data regarding
feature diversity and dynamic range with expected values for comparison. Mix-
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tures of environmental samples have previously been used to evaluate microarray
and RNAseq methods [43, 97, 76, 71]. When used to assess marker-gene surveys,
mixtures of environmental samples can be used to assess count table accuracy, differ-
ential abundance, and beta-diversity. Simulated mixtures of environmental samples
(simulated count tables) have previously been used to evaluate deferentially abun-
dant features and beta diversity [62].
A limitation to using mixtures of environmental samples is the uncertainty
in the expected values. Expected value estimates are based on information from
the unmixed samples and the mixture design. Measurement values obtained for the
unmixed samples are generally obtained using the same measurement process be-
ing assessed, and therefore, measurement uncertainty may not be well understood.
Using the same measurement process and technical replicates allows for the quantifi-
cation of the measurement uncertainty, but provides no information about potential
measurement biases. In addition to uncertainty in the unmixed sample values,
there may be uncertainty in the mixture design, both of which can be estimated.
For RNAseq studies, since the sequencing assay targets mRNA, the proportion of
mRNA in the RNA extract needs to be accounted for in the mixture equation [71].
Similarly for 16S rRNA marker-gene surveys, as the PCR assay targets prokaryotic





Assessing 16S marker-gene survey data analysis methods
using mixtures of human stool sample DNA extracts.
3.1 Abstract
16S rRNA marker-gene surveys use targeted sequencing to characterize prokary-
otic microbial communities. Analysis of these studies is confronted with numerous
bioinformatic pipelines and downstream analysis methods, with limited guidance
on how to decide between appropriate methods from simulation studies or limited
complexity benchmark studies. Appropriate data sets and statistics for assessing
these methods are needed. A mixture of environmental samples is one approach
for generating assessment data sets with the real data complexity while providing
an expected value. We developed a mixture dataset for assessing 16S rRNA bioin-
formatic pipelines and downstream analysis methods using samples collected from
participants in a Enterotoxigenic Escherichia coli (ETEC) vaccine trial participants.
A two-sample titration mixture design was used where DNA from stool samples prior
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to ETEC exposure was titrated into stools samples collected after exposure, in effect
diluting the amount of ETEC in the mixed sample. The sequencing data were pro-
cessed using multiple bioinformatic pipelines, DADA2 a sequence inference method,
Mothur a de novo clustering method, and QIIME with open-reference clustering.
The pipelines varied in the number of features and proportion of reads passing qual-
ity control but had similar sparsity. The mixture dataset was used to qualitatively
and quantitatively assess the count tables generated using the pipelines. Statisti-
cal tests were used to determine if features only present in unmixed samples and
titrations, unmixed- and titration-specific features, were had abundance value that
could be explained by sampling alone. For Mothur and QIIME less than 5% of
unmixed- and titration-specific feature abundance could not be explained by sam-
pling alone where as for DADA2 greater than 50% of unmixed-specific features and
10% of titration- specific features could not be explained by sampling alone. The
quantitative assessment evaluated pipeline performance by comparing observed to
expected relative and differential abundance values. Expected relative abundance
and differential abundance values were calculated using information from the un-
mixed samples and mixture design. Overall the observed relative abundance and
differential abundance values were consistent with the expected values. We devel-
oped feature-level bias and variance metric to further characterize relative abudance
and differential abundance quantitative performance. Relative abundance feature-
level bias metric was significantly different across the three platforms with DADA2
having the lowest bias, followed by Mothur, and QIIME. The relative abundance
feature-level variance metric and both the differential abundance feature-level bias
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and variance metrics did not differ significantly across the three pipelines. The
dataset and methods developed for this study will serve as a valuable community
resource for assessing 16S rRNA marker-gene survey bioinformatic methods.
3.2 Introduction
Targeted sequencing of the 16S rRNA gene, 16S rRNA marker-gene-surveys,
is a commonly used method for characterizing microbial communities, microbiomes.
The 16S rRNA marker-gene-survey measurement process includes molecular (e.g. PCR
and sequencing) and computational steps (e.g., sequence clustering) [34]. Molecular
steps are used to selectively target and sequence the 16S rRNA gene from prokaryotic
organisms within a sample. The computational steps convert the raw sequence data
into a matrix with feature (e.g., operational taxonomic units) relative abundance
values for each sample [34]. Both molecular and computational measurement process
steps contribute to the overall measurement bias and dispersion [27, 34, 15]. Proper
measurement method evaluation allows for the characterization of how individual
steps impact the measurement processes as a whole and determine where to focus ef-
forts for improving the measurement process. Appropriate datasets and methods are
needed to evaluate the 16S rRNA marker-gene-survey measurement process. A sam-
ple or dataset with “ground truth” is needed to characterize measurement process
accuracy. Numerous studies have evaluated quantitative and qualitative character-
istics of the 16S rRNA measurement process using mock communities, simulated
data, and environmental samples.
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To assess the 16S rRNA sequencing measurement process qualitative charac-
teristics of a mock communities are commonly used [10]. As the number of organisms
in the mock community is known, the total number of features can be compared
to the expected value. The number of observed features in a mock community is
often significantly higher than the expected number of organism [50]. The higher
than expected number of features is often attributed to sequencing and PCR arti-
facts as well as reagent contaminants [14, 42]. A notable exception to this is mock
community benchmarking studies evaluating sequencing inference method, such as
DADA2 [19]. Sequence inference methods aim to reduce the number of sequence ar-
tifacts features. While mock communities have a known value, they lack the feature
diversity and relative abundance dynamic range of real samples [10].
The quantitative characteristics of 16S rRNA sequence data are normally as-
sessed using mock communities and simulated data. Mock communities of equimolar
and staggered concentration are used to assess relative abundance estimate quan-
titative accuracy [50]. Results from relative abundance estimates using mock com-
munities generated from mixtures of DNA have shown taxonomic specific effects
where individual taxa are under or over represented in a sample. These taxonomic
specific effects have been attributed to primer mismatches and DNA extraction bi-
ases [14]. Simulated count tables have been used to assess differential abundance
method, where specific taxa are artificially overrepresented in one set of samples
compared to another [62]. Using simulated data to assess log fold-change estimates
only evaluates computational steps of the measurement process.
Quantitative and qualitative assessment can also be performed using sequence
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data generated from mixtures of environmental samples. While simulated data and
mock communities are useful in evaluating and benchmarking new methods one
needs to consider that methods optimized for mock communities and simulated data
are not necessarily optimized for the sequencing error profile and feature diversity
of real samples. Data from environmental samples, which are real samples, are
often used to benchmark new molecular laboratory and computational methods.
However, without an expected value to compare to, only measurement precision can
be evaluated. By mixing environmental samples, an expected value can be calculated
using information from the unmixed samples and how they were mixed. Mixtures
of environmental samples have previously been used to evaluate gene expression
measurements microarrays and RNAseq data[71, 76, 97].
In the present study, we developed a mixture dataset of extracted DNA from
human stool samples for assessing 16S rRNA sequencing. The mixture datasets were
processed using three bioinformatic pipelines. We developed metrics for qualitative
and quantitative assessment of the bioinformatic pipeline results. The quantita-
tive results were similar across pipelines but the qualitative results varied across
pipelines. We have made both the dataset and metrics developed in this study
publically available for evaluating new bioinformatic pipelines.
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3.3 Methods
3.3.1 Two-Sample Titration Design
Samples collected at multiple timepoints during a Enterotoxigenic E. coli
(ETEC) vaccine trial [38] were used to generate a two-sample titration dataset for
assessing the 16S rRNA marker-gene survey measurement process. Samples from
five trial participants were selected for our two-sample titration dataset. Trial partic-
ipants (subjects) and sampling timepoints were selected based on E. coli abundance
data collected using qPCR and 16S rRNA sequencing from Pop et al. [77]. Only
individuals with no E. coli detected in samples collected from trial participants prior
to ETEC exposure twere used for our two-samples titrations. Post ETEC exposure
(POST) samples were identified as the timepoint after exposure to ETEC with the
highest E. coli concentration for each subject (Fig. 3.1A). Due to limited sample
availability, the timepoint with the second highest concentrations for E01JH0016
was used as the POST sample. Independent titration series were generated for each
subject, where POST samples were titrated into PRE samples with POST propor-
tions of 1/2, 1/4, 1/8, 1/16, 1/32, 1/1,024, and 1/32,768 (Fig. 3.1B). Unmixed
(PRE and POST) sample DNA concentration was measured using NanoDrop ND-
1000 (Thermo Fisher Scientific Inc. Waltham, MA USA). Unmixed samples were
diluted to 12.5 ng/µL in tris-EDTA buffer before making the two-sample titrations.
For our two-sample titration mixture design, the expected feature relative
abundance can be calculated using equation (3.1), where θi, is the proportion of
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POST DNA in titration i, qij is the relative abundance of feature j in titration i,
and the relative abundance of feature j in the unmixed PRE and POST samples is
qpre,j and qpost,j.
qij = θiqpost,j + (1 − θi)qpre,j (3.1)
3.3.2 Titration Validation
qPCR was used to validate volumetric mixing and check for differences in the
proportion of prokaryotic DNA across titrations. To ensure that the two-sample
titrations were volumetrically mixed according to the mixture design, independent
ERCC plasmids were spiked into the unmixed PRE and POST samples [4] (NIST
SRM SRM 2374) (Table 3.2). The ERCC plasmids were resuspended in 100 ng/µL
tris-EDTA buffer and 2 ng/µL was spiked into the appropriate unmixed sample.
Plasmids were spiked into unmixed samples after unmixed sample concentration
was normalized to 12.5 ng/µL. POST sample ERCC plasmid abundance was quan-
tified using TaqMan gene expression assays (FAM-MGB) (Catalog # 4448892, Ther-
moFisher) specific to each ERCC plasmid using the TaqMan Universal MasterMix II
(Catalog # 4440040, ThermoFisher Waltham, MA USA). To check for differences in
the proportion of bacterial DNA in the PRE and POST samples, titration bacterial
DNA concentration was quantified using the Femto Bacterial DNA quantification
kit (Zymo Research, Irvine CA). All samples were run in triplicate along with an
in-house E. coli DNA log10 dilution standard curve. qPCR assays were performed
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Figure 3.1: Sample selection and experimental design for the two-sample titration
16S rRNA marker-gene-survey assessment dataset. A) Pre- and post-exposure
(PRE and POST) samples from five vaccine trial participants were selected based
on Escherichia coli abundance measured using qPCR and 454 16S rRNA se-
quencing (454-NGS), data from Pop et al. [77]. PRE and POST samples are
indicated with orange and green data points, respectively. Grey points are other
samples from the vaccine trial time series. B) Proportion of DNA from PRE and
POST samples in titration series samples. PRE samples were titrated into POST
samples following a log2 dilution series. The NA titration factor represents the
unmixed PRE sample. C) PRE and POST samples from the five vaccine trial
participants, subjects, were used to generate independent two-sample titration
series. The result was a total of 45 samples, 7 titrations + 2 unmixed samples
times 5 subjects. Four replicate PCRs were performed for each of the 45 samples
resulting in 190 PCRs.
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using the QuantStudio Real-Time qPCR (ThermoFisher). Amplification data and
Ct values were exported as tsv files using QuantStudio Design and Analysis Soft-
ware v1.4.1. Statistical analysis was performed on the exported data using custom
scripts in R [80, https://github.com/nate-d-olson/mgtst_pub].
3.3.3 Sequencing
The 45 samples (seven titrations and two unmixed samples for each of five
subjects) were processed using the Illumina 16S library protocol (16S Metagenomic
Sequencing Library Preparation, posted date 11/27/2013, downloaded from http
s://support.illumina.com). This protocol specifies an initial 16S rRNA PCR
followed by a sample indexing PCR, followed by normalization and sequencing.
A total of 192 16S rRNA PCR assays were run including four replicates per
sample and 12 no-template controls, using Kapa HiFi HotStart ReadyMix reagents
(KAPA Biosystems, Inc. Wilmington, MA). The initial PCR assay targeted the V3-
V5 region of the 16S rRNA gene, Bakt 341F and Bakt 806R [48]. The V3-V5 region
is 464 base pairs (bp) long, with forward and reverse reads overlapping by 136 bp,
using 2 X 300 bp paired-end sequencing [110] ( http://probebase.csb.univie.a
c.at). Primer sequences include overhang adapter sequences for library prepara-
tion (forward primer 5’- TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGC-
CTACGGGNGGCWGCAG - 3’ and reverse primer 5’- GTCTCGTGGGCTCGGA-
GATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC - 3’). For quality
control, the PCR product was verified using agarose gel electrophoresis to check for
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appropriate size bands, and concentration measurements were made after the initial
16S rRNA PCR, the indexing PCR, and normalization steps. DNA concentration
was measured using SpextraMax Accuclear Nano dsDNA Assay Bulk Kit (Part#
R8357#, Lot 215737, Molecular Devices LLC. Sunnyvale CA, USA) and fluorescent
measurements were made with a Molecular Devices SpectraMax M2 spectraflourom-
eter (Molecular Devices LLC. Sunnyvale CA, USA).
Initial PCR products were purified using AMPure XP beads (Beckman Coulter
Genomics, Danvers, MA) following the manufacturer’s protocol. After purification,
the 192 samples were indexed using the Illumina Nextera XT index kits A and D
(Illumina Inc., San Diego CA). Prior to pooling purified sample concentration was
normalized using SequalPrep Normalization Plate Kit (Catalog n. A10510-01, In-
vitrogen Corp., Carlsbad, CA), according to the manufacturer’s protocol. Pooled
library concentration was checked using the Qubit dsDNA HS Assay Kit (Part#
Q32851, Lot# 1735902, ThermoFisher, Waltham, MA USA). Due to the low pooled
amplicon library DNA concentration, a modified protocol for low concentration li-
braries was used. The library was run on an Illumina MiSeq, and base calls were
made using Illumina Real Time Analysis Software version 1.18.54. Sequencing data
quality control metrics for the 384 fastq sequence files (192 samples with forward
and reverse reads) were computed using the Bioconductor Rqc package [93, 39].
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3.3.4 Sequence Processing
Sequence data were processed using four bioinformatic pipelines: a de-novo
clustering method - Mothur [89], an open-reference clustering method - QIIME [21],
and a sequence inference methods - DADA2 [19], and unclustered sequences as a
control. The code used to run the bioinformatic pipelines is available at https:
//github.com/nate-d-olson/mgtst_pipelines.
The Mothur pipeline follows the developers MiSeq SOP [89, 51]. The pipeline
was run using Mothur version 1.37 (http://www.mothur.org/) As we sequenced a
larger 16S rRNA region, with smaller overlap between the forward and reverse reads,
than the 16S rRNA region the SOP was designed. Pipeline parameters were modified
to account for the difference in overlap are noted for individual steps below. The
Makefile and scripts used to run the mothur pipeline are available https://github
.com/nate-d-olson/mgtst_pipelines/blob/master/code/mothur. The Mothur
pipeline included an initial preprocessing step where the forward and reverse reads
are trimmed and filtered using base quality scores merged into contigs. The following
parameters were used for the initial contig filtering, no ambiguous bases, max contig
length of 500 bp, and max homopolymer length of 8 bases. For the initial read
filtering and merging step, low-quality reads were identified and filtered from the
dataset based on the presence of ambiguous bases, failure to align to the SILVA
reference database (V119, https://www.arb-silva.de/) [79], and identification as
chimeras. Prior to alignment, the SILVA reference multiple sequence alignment was
trimmed to the V3-V5 region, positions 6,388 and 25,316. Chimera filtering was
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performed using UChime (version v4.2.40) without a reference database [32]. OTU
clustering was performed using the OptiClust algorithm with a clustering threshold
of 0.97 [103]. The RDP classifier implemented in mothur was used for taxonomic
classification against the mothur provided version of the RDP v9 training set [101].
The QIIME open-reference clustering pipeline for paired-end Illumina data was
performed according to the online tutorial (http://nbviewer.jupyter.org/githu
b/biocore/qiime/blob/1.9.1/examples/ipynb/illumina_overview_tutorial.i
pynb) using QIIME version 1.9.1 [21]. Briefly, the QIIME pipeline uses fastq-join
(version 1.3.1) to merge paired-end reads [3] and the Usearch algorithm [29] with
Greengenes database version 13.8 with a 97% similarity threshold [28] was used for
open-reference clustering.
DADA2, an R native pipeline was also used to process the sequencing data
[19]. The pipeline includes a sequence inference step and taxonomic classification
using the DADA2 implementation of the RDP naïve Bayesian classifier [101] and the
SILVA database V123 provided by the DADA2 developers [79, https://benjjneb.
github.io/dada2/training.html].
The unclustered pipeline was based on the mothur de-novo clustering pipeline,
where the paired-end reads were merged, filtered, and then dereplicated. Reads were
aligned to the reference Silva alignment (V119, https://www.arb-silva.de/), and
reads failing alignment were excluded from the dataset. Taxonomic classification of
the unclustered sequences was performed using the same RDP classifier implemented
in mothur used for the de-novo pipeline. To limit the size of the dataset the most
abundant 40,000 OTUs (comparable to the mothur dataset), across all samples,
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were used as the unclustered dataset.
3.3.5 Titration Proportion Estimates
The following linear model (3.2) was used to infer the proportion of prokary-
otic DNA in each titration, θ. Where Qi is a vector of titration i feature relative
abundance estimates and Qpre and Qpost are vectors of feature relative abundance
estimates for the unmixed PRE and POST samples. Average PCR replicate relative
abundance values were calculated using a negative binomial model.
Qi = θi(Qpost − Qpre) + Qpre (3.2)
To fit the model to prevent uninformative and low abundance features from
biasing θ estimates only informative features meeting the following criteria were
used Features included in the model were observed in at least 14 of the 28 total
titration PCR replicates (4 replicates per 7 titrations), demonstrated greater than
2-fold difference in relative abundance between the PRE and POST samples, and
were present in either all four or none of the PRE and POST PCR replicates.
16S rRNA sequencing count data is known to have a non-normal mean-variance
relationship resulting in poor model fit for standard linear regression [62]. General-
ized linear models provide an alternative to standard least-squares regression. The
above model is additive and therefore unable to directly infer θi in log-space. To
address this issue, we fit the model using a standard least-squares regression then
obtained non-parametric 95 % confidence intervals for the θ estimates by bootstrap-
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ping with 1000 replicates.
3.3.6 Qualitative Assessment
Our qualitative measurement assessment evaluated features only observed in
unmixed samples (PRE or POST), unmixed-specific, or titrations,titration-specific.
Unmixed- or titration-specific features are due to differences in sampling depth (num-
ber of sequences) between the unmixed samples and titrations, artifacts of the fea-
ture inference process, or PCR/sequencing artifacts. Measurement process artifacts
should be considered false positives or negatives. Hypothesis tests were used to
determine if differences in sampling depth could account for unmixed-specific and
titration-specific features. p-values were adjusted for multiple comparisons using the
Benjamini & Hochberg method [8]. For unmixed-specific features, the binomial test
was used to evaluate if true feature relative abundance is less than the expected
relative abundance. A binomial test could not be used to evaluate titration-specific
features, as the hypothesis would be formulated as such. Given observed counts and
the titration total feature abundance, the true feature relative abundance is equal
to 0. As non-zero counts were observed the true feature proportion is non-zero,
and the test always fails. Therefore, we formulated a Bayesian hypothesis test for
titration-specific features.
A Bayesian hypothesis test was used to evaluate if the true feature proportion
is less than the minimum detected proportion. The Bayesian hypothesis test was
formulated using equation (3.3). Which when assuming equal priors, P (π < πmin) =
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P (π ≥ πmin), reduces to (3.4). For equations (3.3) and (3.4) π is the true feature
proportion, πmin is the minimum detected proportion, C is the expected feature
counts, and Cobs is the observed feature counts. Simulation was used to generate
possible values of C, assuming C has a binomial distribution given the observed
sample total feature abundance, and a uniform probability distribution for π between
0 and 1. πmin was calculated using the mixture equation (3.1) where qpre,j and qpost,j
are min(Qpre) and min(Qpost) across all features for a subject and pipeline. Our
assumption is that π is less than πmin for features not observed in unmixed samples
due to random sampling.
p = P (π < πmin|C ≥ Cobs)
= P (C ≥ Cobs|π < πmin)P (π < πmin)
P (C ≥ Cobs|π < πexp)P (π < πmin) + P (C ≥ Cobs|π ≥ πmin)P (π ≥ πmin)
(3.3)
p = P (C ≥ Cobs|π < πmin)
P (C ≥ Cobs)
(3.4)
3.3.7 Quantitative Assessment
Quantitative assessment compared observed relative abundance and log fold-
changes to expected values derived from the titration experimental design. Feature
average relative abundance across PCR replicates was calculated using a negative
binomial model, and used as observed relative abundance values (obs) for the relative
42
abundance assessment. Average relative abundance values were used to reduce PCR
replicate outliers from biasing the assessment results. Equation (3.1) and inferred θ
values were used to calculate the expected relative abundance values (exp). Relative
abundance error rate is defined as |exp − obs|/exp.
We developed bias and variance metrics to assess feature performance. The
feature-level bias and variance metrics were defined as the median error rate and
robust coefficient of variation (RCOV = IQR/median) respectively. Mixed-effects
models were used to compare feature-level error rate bias and variance metrics across
pipelines with subject as a random effect. Extreme feature-level error rate bias
and variance metric outliers were observed, these outliers were excluded from the
mixed effects model to minimize biases due to poor model fit and were characterized
independently.
Log fold-change between samples in the titration series including PRE and
POST were compared to the expected log fold-change values to assess differential
abundance log fold-change estimates. Log fold-change estimates were calculated
using EdgeR [84, 58]. Expected log fold-change for feature j between titrations l
and m is calculated using equation (3.5), where θ is the proportion of POST bacterial
DNA in a titration, and q is feature relative abundance. For features only present
in PRE samples the expected log fold-change is independent of the observed counts
for the unmixed samples and is calculated using (3.6). Due to a limited number
of PRE-specific features, both PRE-specific and PRE-dominant features were used
in the differential abundance assessment. PRE-specific features were defined as
features observed in all four PRE PCR replicates and not observed in any of the
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Table 3.1: Summary statistics for the different bioinformatic pipelines. DADA2 is a
denoising sequence inference pipeline, QIIME is an open-reference clustering pipeline,
and mothur is a de-novo clustering pipeline. No template controls were excluded from
summary statistics. Sparsity is the proportion of 0’s in the count table. Features is the
total number of OTUs (QIIME and mothur) or SVs (DADA2) in the count. Sample
coverage is the median and range (minimum-maximum) per sample total abundance.
Drop-out rate is the proportion of reads removed while processing the sequencing data
for each bioinformatic pipeline.
Pipelines Features Sparsity Total Abundance Drop-out Rate
DADA2 3144 0.93 68649 (1661-112058) 0.24 (0.18-0.59)
Mothur 38469 0.98 53775 (1265-87806) 0.4 (0.35-0.62)
QIIME 11385 0.94 25254 (517-46897) 0.7 (0.62-0.97)
POST PCR replicates and PRE-dominant features were also observed in all four
PRE PCR replicates and observed in one or more of the POST PCR replicates with
a log fold-change between PRE and POST samples greater than 5.
logFClm,j = log2
(
θlqpost,j + (1 − θl)qpre,i











We first characterize the number of reads per sample and base quality score
distribution. The number of reads per sample and distribution of base quality scores






















Subject E01JH0004 E01JH0011 E01JH0016 E01JH0017 E01JH0038
Figure 3.2: Sequence dataset characteristics. (A) Distribution in the number of
reads per barcoded sample (Library Size) by individual. The dashed horizontal
line indicates overall median library size. Excluding one PCR replicate from
subject E01JH0016 titration 5 that had only 3,195 reads. (B) Smoothing spline
of the base quality score (BQS) across the amplicon by subject. Vertical lines
indicate approximate overlap region between forward and reverse reads. Forward
reads go from position 0 to 300 and reverse reads from 464 to 164.
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DADA2 Mothur QIIME




















Individual E01JH0004 E01JH0011 E01JH0016 E01JH0017 E01JH0038
Figure 3.3: Relationship between the number of reads and features per sample by
bioinformatic pipeline. (A) Scatter plot of observed features versus the number of
reads per sample. (B) Observed feature distribution by pipeline and individual.
Excluding one PCR replicate from subject E01JH0016 titration 5 with only 3,195
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Figure 3.4: Comparison of dataset taxonomic composition across pipelines. Phy-
lum (A) and Order (B) relative abundance by pipeline. Taxonomic groups with
less than 1% total relative abundance were grouped together and indicated as
other. Pipeline genus-level taxonomic assignment set overlap for the all features
(C) and the upper quartile genera by relative abundance for each pipeline (D).
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samples had less than 35,000 reads. The rest of the samples with less than 35,000
reads were no template PCR controls (NTC). Excluding the one failed reaction with
2,700 reads and NTCs, there were 8.9548 × 104 (3195-152267, median and range)
sequnces per sample. The forward read has consistently higher base quality scores
relative to the reverse read with a narrow overlap region with high base quality
scores for both forward and reverse reads (Fig. 3.2B).
The resulting count tables generated using the four bioinformatic pipelines
were characterized for number of features, sparsity, and filter rate(Table 3.1, Figs.
3.3B). The pipelines evaluated employ different approaches for handling low quality
reads resulting in the large differences in drop-out rate and the fraction of raw
sequences not included in the count table (Table 3.1). QIIME pipeline has the
highest drop-out rate and number of features per sample but fewer total features
than Mothur. The targeted amplicon region has a relatively small overlap region,
136 bp for 300 bp paired-end reads, compared to other commonly used amplicons
[51, 100]. The high drop-off rate is due to low basecall accuracy at the ends of the
reads especially the reverse reads resulting in a high proportion of unsuccessfully
merged reads pairs (Fig. 3.2B). Furthermore increasing the drop-out rate, QIIME
excludes singletons, OTUs only observed once in the dataset, to remove potential
sequencing artifacts from the dataset. QIIME and DADA2 pipelines were similarly
sparse (the fraction of zero values in count tables) despite differences in the number
of features and drop-out rate. The expectation is that this mixture dataset will be
less sparse relative to other datasets due to the redundant nature of the samples
where 35 of the samples are derived directly from the other 10 samples, and four PCR
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replicates for each sample. With sparsity greater than 0.9 for the three pipelines
it is unlikely that any of the pipelines successfully filtered out a majority of the
sequencing artifacts.
The dataset taxonomic assignments also varied by pipeline (Fig. 3.4). Phylum
and order relative abundance is similar across pipelines (Fig. 3.4A & B). Differences
are attributed to different taxonomic classification methods and databases. The
DADA2 and QIIME pipelines differed from Mothur and QIIME for Proteobacteria
and Bacteriodetes. Regardless of threshold, for genus sets most genera were unique
to individual pipelines (Fig. 3.4C & D). Sets with QIIME had the fewest genera,
excluding the DADA2-QIIME set. QIIME pipeline was the only one to use the open-
reference clustering and the Greengenes database. Mothur and DADA2 both used
the SILVA dataset. The Mothur and DADA2 pipeline use different implmentations
of the RDP naïve Bayesian classifier, which may be partially responsible for the
mothur, unclustered, and DADA2 differences.
3.4.2 Titration Series Validation
To validate the two-sample titration dataset for use in abundance assessment
we evaluated two assumptions about the titrations: 1. The samples were mixed
volumetrically in a log2 dilution series according to the mixture design. 2. The
unmixed PRE and POST samples have the same proportion of prokaryotic DNA. To
validate the sample volumetric mixing exogenous DNA was spiked into the unmixed
samples before mixing and quantified using qPCR . To evaluate if the PRE and
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POST samples had the same proportion of prokaryotic DNA total prokaryotic DNA
in the titrations samples was quantified using a qPCR assay targeting the 16S rRNA
gene.
3.4.2.1 Spike-in qPCR results
Titration series volumetric mixing was validated by quantify ERCC plasmids
spiked into the POST samples using qPCR. The qPCR assay standard curves had a
high level of precision with R2 values close to 1 and amplification efficiencies between
0.84 and 0.9 for all standard curves indicating the assays were suitable for validating
the titration series volumetric mixing (Table 3.2). For our log2 two-sample-titration
mixture design the expected slope of the regression line between titration factor and
Ct is 1, corresponding to a doubling in template DNA every PCR cycle. The qPCR
assays targeting the ERCCs spiked into the POST samples had R2 values and slope
estimates close to 1 (Table 3.2). Slope estimates less than one were attributed to
assay standard curve efficiency less than 1 (Table 3.2). ERCCs spiked into PRE
samples were not used to validate volumetric mixing as PRE sample proportion
differences were too small for qPCR quantification. The expected Ct difference for
the entire range of PRE concentrations in only 1. When considering the quantitative
limitations of the qPCR assay these results confirm that the unmixed samples were
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Figure 3.5: Prokaryotic DNA concentration (ng/ul) across titrations measured
using a 16S rRNA qPCR assay. Separate linear models, Prokaryotic DNA con-
centration versus θ were fit for each individual, and R2 and p-values were re-
ported. Red lines indicate negative slope estimates and blue lines positive slope
estimates. p-value indicates significant difference from the expected slope of 0.
Multiple test correction was performed using the Benjamini-Hochberg method.
One of the E01JH0004 PCR replicates for titration 3 (θ = 0.125) was identified
as an outlier, with a concentration of 0.003, and was excluded from the linear
model. The linear model slope was still significantly different from 0 when the
outlier was included.
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Table 3.2: ERCC Spike-in qPCR assay information and summary statistics. ERCC is
the ERCC identifier for the ERCC spike-in, Assay is TaqMan assay, and Length and
GC are the size and GC content of the qPCR amplicon. The Std. R2 and Efficiency
(E) statistics were computed for the standard curves. R2 and slope for titration qPCR
results for the titration series.
Subject ERCC Assay Length Std. R2 E R2 Slope
E01JH0004 012 Ac03459877-a1 77 0.9996 86.19 0.98 0.92
E01JH0011 157 Ac03459958-a1 71 0.9995 87.46 0.95 0.90
E01JH0016 108 Ac03460028-a1 74 0.9991 87.33 0.95 0.84
E01JH0017 002 Ac03459872-a1 69 0.9968 85.80 0.89 0.93
E01JH0038 035 Ac03459892-a1 65 0.9984 86.69 0.95 0.94
3.4.2.2 Bacterial DNA Concentration
The observed changes in prokaryotic DNA concentration across titrations in-
dicate the proportion of bacterial DNA from the unmixed PRE and POST samples
in a titration is inconsistent with the mixture design (Fig. 3.5). A qPCR assay
targeting the 16S rRNA gene was used to quantify the concentration of prokary-
otic DNA in the titrations. An in-house standard curve with concentrations of 20
ng/ul, 2ng/ul, and 0.2 ng/ul was used, with efficiency 91.49, and R2 0.999. If the
proportion of prokaryotic DNA is the same between PRE and POST samples the
slope of the concentration estimates across the two-sample titration would be 0. For
subjects where the proportion of prokaryotic DNA is higher in the PRE samples,
the slope will be negative and positive when the proportion is higher for POST sam-
ples. The slope estimates are significantly different from 0 for all subjects excluding
E01JH0011 (Fig. 3.5). These results indicate that the proportion of prokaryotic
DNA is lower in POST when compared to the PRE samples for E01JH0004 and
E01JH0017 and higher for E01JH0016 and E01JH0038.
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3.4.2.3 Theta Estimates
To account for differences in the proportion of prokaryotic DNA in PRE and
POST samples (Fig. 3.5) we inferred the proportion of POST sample prokaryotic
DNA in a titration, θ, using the 16S rRNA sequencing data (Fig. 3.6). Overall the
relationship between the inferred and mixture design θ values were consistent across
pipelines but not subject whereas the 95% CI varied by both subject and pipeline.
For study subjects E01JH0004, E01JH0011, and E01JH0016 the inferred and mix-
ture design θ values were in agreement, in contrast, to study subjects E01JH0017
and E01JH0038. For E01JH0017 the inferred values were consistently less than
the mixture design values. Whereas for E01JH0038 the inferred values were consis-
tently greater than the mixture design values. These results were consistent with
the qPCR prokaryotic DNA concentration results with significantly positive slopes
for E01JH0004 and E01JH0016 and a significantly negative slope for E01JH0038
(Fig. 3.5).
3.4.3 Measurement Assessment
Next, we assessed the qualitative and quantitative nature of 16S rRNA mea-
surement process using our two-sample titration dataset. For the qualitative assess-
ment, we analyzed the relative abundance of features only observed in the unmixed
samples or titrations which are not expected given the titration experimental design.
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Figure 3.6: Theta estimates by titration, biological replicate, and bioinformatic
pipeline. The points indicates mean estimate of 1000 bootstrap theta estimates
and errorbars 95% confidence interval. The black bar indicate expected theta
values. Theta estimates below the expected theta indicate that the titrations con-
tain less than expected bacterial DNA from the POST sample. Theta estimates
greater than the expected theta indicate the titration contains more bacterial


























































































Figure 3.7: Distribution of (A) observed count values for titration-specific fea-
tures and (B) expected count values for unmixed-specific features by pipeline
and individual. The orange horizontal dashed line indicates a count value of 1.
(C) Proportion of unmix-specific features and (D) titration-specific features with
an adjusted p-value < 0.05 for the Bayesian hypothesis test and binomial test
respectively. We failed to accept the null hypothesis when the p-value < 0.05,
indicating that the discrepancy between the feature only being observed in the
titrations or unmixed samples cannot be explained by sampling alone.
3.4.3.1 Qualitative Assessment
Unmixed- and titration-specific features were observed for all pipelines (titration-
specific: Fig. 3.7A, unmixed-specific: Fig. 3.7B). For mixture datasets the low
abundance features present only in the unmixed samples and mixtures are expected
due to random sampling. For our two-sample titration dataset there were unmixed-
specific features with expected counts that could not be explained by sampling alone
for all individuals and bioinformatic pipelines (Fig. 3.7C). However, the proportion
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Table 3.3: Maximum feature-level error rate bias (median error rate) and variance (robust
COV) by pipeline and individual.
Metric Pipeline E01JH0004 E01JH0011 E01JH0016 E01JH0017 E01JH0038
dada2 2.37 2.55 17.03 4.34 0.66
mothur 5.30 6.76 19.24 4.15 1.93
qiime 3.99 6.43 8.83 4.80 1.09Bias
unclustered 6.45 7.24 16.85 4.37 1.91
dada2 4.60 8.96 7.36 5.91 6.71
mothur 4.71 7.35 3.71 5.70 8.01
qiime 4.40 22.57 4.46 17.10 7.91Variance
unclustered 7.06 10.30 16.94 8.07 6.00
of unmixed-specific features that could not be explained by sampling alone varied
by bioinformatic pipeline. DADA2 had the highest rate of unmixed-specific features
not explained by sampling whereas QIIME had the lowest rate. Consistent with the
distribution of observed counts for titration-specific features more of the DADA2
features could not be explained by sampling alone compared to the other pipelines
(Fig. 3.7D). Overall, DADA2 resulted in the largest number of observed features
inconsistent with the titration experiment design, while the same phenomenon is
significantly reduced in the other pipelines.
3.4.3.2 Quantitative Assessment
For the relative abundance assessment, I evaluated the consistency of the ob-
served and expected relative abundance estimates for a feature and titration as well
as feature-level bias and variance. The PRE and POST estimated relative abun-
dance and inferred θ values were used to calculate titration and feature level error
rates. Unclustered pipeline θ estimates were used to calculate the error rates for all
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E01JH0004 E01JH0011 E01JH0016 E01JH0017 E01JH0038





















Pipeline dada2 mothur qiime unclustered
Figure 3.8: Relative abundance assessment. (A) A linear model of the relationship
between the expected and observed relative abundance. The dashed grey line
indicates expected 1-to-1 relationship. The plot is split by individual and color is
used to indicate the different bioinformatic pipelines. A negative binomial model
was used to calculate an average relative abundance estimate across the four PCR
replicates. Points with observed and expected relative abundance values less than
1/median library size were excluded from the data used to fit the linear model.





























Pipeline dada2 mothur qiime unclustered
Figure 3.9: Comparison of pipeline relative abundance assessment feature-level
error metrics. Distribution of feature-level relative abundance (A) bias metric -
median error rate and (B) variance - robust coefficient of variation (RCOV =
(IQR)/|median|) by individual and pipeline. Boxplot outliers, 1.5 × IQR from
the median were excluded from the figure to prevent extreme metric values from
obscuring metric value visual comparisons.
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pipelines to prevent over-fitting. Only features observed in all PRE and POST PCR
replicates and PRE and POST specific features were included in the analysis (Ta-
ble 3.3). PRE and POST specific features were defined as present in all four PCR
replicates of the PRE or POST PCR replicates, respectively, but none of the PCR
replicates for the other unmixed samples. There is lower confidence in PRE or POST
feature relative abundance when the feature is not observed in some of the 4 PCR
replicates, therefore these features were not included in the error analysis. Overall,
agreement between the inferred and observed relative abundance was high for all
individuals and bioinformatic pipelines (Fig. 3.8A). The error rate distribution was
similarly consistent across pipelines, including long tails (Fig. 3.8B)
To assess quantitative accuracy I compared the feature-level relative abun-
dance error rate bias (median error rate, Fig. 3.9A) and variance (RCOV =
(IQR)/|median| Fig. 3.9B) across pipelines and individuals using mixed effects
models. Large bias and variance values were observed for all pipelines (Table 3.3).
Features with large bias and variance metrics (outliers), defined as 1.5 × IQR from
the median. To prevent the outliers from biasing the comparison they were not in-
cluded in the dataset used to fit the mixed effects model. Multiple comparisons test
(Tukey) was used to test for significant differences in feature-level bias and variance
between pipelines. A one-sided alternative hypothesis was used to determine which
pipelines had a smaller, feature-level error rate. The Mothur, DADA2, and QIIME
feature-level bias were all significantly different from each other (p < 1 × 10−8).
DADA2 had the lowest mean feature-level bias (0.2), followed by Mothur (0.28),
with QIIME having the highest bias (0.33) (3.9B). Large variance metric values
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Pipeline dada2 mothur qiime unclustered
Figure 3.10: (A) Linear model or the relationship between log fold-change es-
timates and expected values for PRE-specific and PRE-dominant features by
pipeline and individual, line color indicates pipelines. Dashed grey line indicates
expected 1-to-1 relationship between the estimated and expected log fold-change.
(B) Log fold-change error (|exp-est|) distribution by pipeline and individual.
were observed for all individuals and pipelines (Table 3.3). The feature-level vari-
ance was not significantly different between pipelines, Mothur = 0.83, QIIME = 0.71
and DADA2 = 1 (Fig. 3.9B). I evaluated whether poor feature-level relative abun-
dance metrics can be attributed to specific taxonomic groups or phylogenetic clades.
While a significant overall phylogenetic signal was detected for both the bias and
variance metric, I was unable to identify specific taxonomic groups or phylogenetic
clades exceedingly poor performance in our assessment.
The agreement between the log-fold change estimates and expected values were





















Pipeline dada2 mothur qiime unclustered
Figure 3.11: Feature-level log-fold change error bias (A) and variance (B) metric
distribution by subject and pipeline. The bias (1 − slope) and variance (R2)
metrics are derived from the linear model fit to the estimated and expected log
fold-change values for individual features. Boxplot outliers, 1.5 × IQR from the
median were excluded from the figure to prevent extreme metric values from
obscuring metric value visual comparisons.
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cific effect was attributed to the fact that unlike the relative abundance assessment
the inferred θ values were not used to calculate the expected values. The inferred θ
values were not used to calculate the expected values as I wanted to include all of
the titrations and the θ estimates for the higher titrations were not monotonically
decreasing and therefore resulted in unrealistic expected log fold-change values, e.g.,
negative log-fold changes for PRE specific features. The log-fold change estimates
and expected values were consistent across pipelines with one notable exception. For
E01JH0011 the Mothur log fold-change estimates were in better agreement with the
expected value compared to the other pipelines. However, as θ was not corrected
for differences in the proportion of prokaryotic DNA between the unmixed PRE and
POST samples I am unable to say whether Mothur’s performance was better than
the other pipelines.
The log fold-change error distribution was consistent across pipelines (Fig.
3.10B). There was a long tail of high error features in the error distribution for all
pipelines and individuals. The log fold-change estimates responsible for the long tail
could not be attributed to specific titration comparisons. Additionally, I compared
the log-fold change error distribution for log-fold change estimates using different
normalization methods. The error rate distributions, including the long tails, were
consistent across normalization methods. Furthermore, as the long tail was observed
for the unclustered data as well, the log-fold change estimates contributing to the
long tail are likely due to a bias associated with the molecular laboratory portion of
the measurement process and not the bioinformatic pipelines. Based on exploratory
analysis of the relationship between the log fold-change estimates and expected
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values for individual features indicated that the long tails were attributed to feature
specific performance.
Feature-level log fold-change bias and variance metrics were used to compare
pipeline performance (Fig. 3.10). Feature-level bias and variance metrics are de-
fined as the 1 − slope and R2 for linear models of the estimated and expected log
fold-change for individual features and all titration comparisons. For the bias met-
ric, 1 − slope, the desired value is 0 (i.e., log fold-change estimate = log fold-change
expected), with negative values indicating the log-fold change was consistently un-
derestimated and positive values consistently overestimated. The linear model R2
value was used to characterize the feature-level log fold-change variance as it indi-
cates how consistent the relationship between log fold-change estimates and expected
values is across titration comparisons. To compare bias and variance metrics across
pipelines mixed-effects models were used. The log fold-change bias and variance
metrics were not significantly different between pipelines (Bias: F = 0, 2.51, p =
0.99, 0.08, 3.10B, Variance: F = 47.39, 0.23, p = 0, 0.8, Fig. 3.10C). Next, I eval-
uated whether poor feature-level metrics could be attributed to specific clades for
taxonomic groups. Similar to the relative abundance estimate, while a phylogenetic
signal was detected for both the bias and variance metrics, I was unable to iden-




We assessed the quantitative and qualitative characteristics of count tables
generated using different bioinformatic pipelines and 16S rRNA marker-gene sur-
vey mixture dataset. The mixture dataset followed a two-sample titration mixture
design, where DNA collected before and after exposure to pathogenic Escherichia
coli from five vaccine trial participants (subjects) were mixed following a log2 di-
lution series (Fig. 3.1). Qualitative count table characteristics were assessed using
relative abundance information for features observed only in titrations and unmixed
samples. We quantitatively assed count tables by comparing feature relative and
differential abundance to expected values.
3.5.1 Count Table Assessment Demonstration
We demonstrated our novel assessment approach by evaluating count tables
generated using different bioinformatic pipelines, QIIME, Mothur, and DADA2. The
Mothur pipeline uses de novo clustering for feature inference [103, 89]. Pairwise dis-
tances used in clustering are calculated using a multiple sequence alignment. The
quality filtered paired-end reads are merged into contigs. The pipeline the aligns
contigs to a reference multiple sequence alignment and removes uninformative posi-
tions in the multiple sequence alignment. The QIIME pipeline uses open-reference
clustering where merged paired-end reads are first assigned to reference cluster cen-
ters [82, 21]. Next QIIME clusters unassigned reads de novo. Unlike Mothur, the
QIIME clustering method uses pairwise sequence distances calculated from pairwise
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sequence alignments. As a result, the QIIME pairwise distances are calculated using
the full ˜436 bp sequences whereas Mothur pairwise distances were calculated us-
ing a 270 bp multiple sequence alignment. The DADA2 pipeline uses a probability
model and maximization expectation algorithm for feature inference [19]. Unlike
distance-based clustering methods employed by the Mothur and QIIME pipelines,
DADA2 parameters determine if low abundance sequences are grouped with a higher
abundance sequence. As a control, we compared our quantitative assessment results
for the three pipelines to a count table of unclustered features. The unclustered
features were generated using the Mothur pipeline preprocessing methods.
3.5.1.1 Quantitative Assesssment
While the relative abundance bias metric was significantly different between
pipelines overall, pipeline choice had minimal impact on the quantitative assess-
ment results when accounting for subject-specific effects. Outlier features, those
with extreme quantitative analysis bias and variance metrics, were observed for all
pipelines and both relative and differential abundance assessments. Outlier features
could not be attributed to bioinformatic pipelines and are likely due to biases in
the molecular biology part of the measurement process. Outlier features are not
likely a pipeline artifact as they were observed in count tables generated using the
unclustered pipeline as well as standard bioinformatic pipelines. We were unable
to attribute outlier features to relative abundance values, log fold-change between
unmixed samples, and sequence GC content. Features with extreme metric values
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were not limited to any specific taxonomic group or phylogenetic clade. PCR am-
plification is a well-known bias molecular biology component of the measurement
process. Mismatches in the primer binding regions impact PCR efficiency and are
a potential cause for poor feature-specific performance [109]. Additional research is
needed before outlier features are attributed to mismatches in the primer binding
regions.
3.5.1.2 Qualitative Assessment
The qualitative assessment evaluated whether features only observed in un-
mixed samples or titrations could be explained by sampling alone. Features present
only in the titrations or unmixed samples not due to random sampling are bioin-
formatic pipeline artifacts. These artifacts can be categorized as false negative or
false positive features. A false negative occurs when a lower abundance sequence
representing an organism within the sample is clustered with a higher abundance
sequence from a different organism. False positives are sequencing or PCR artifacts
not appropriately filtered or assigned to an appropriate feature by the bioinformatic
pipeline.
Count table sparsity, the proportion of zero-valued cells, provides additional
insight into the qualitative assessment results. A high rate of false negative fea-
tures is a potential explanation for the DADA2 count table’s poor performance in
the qualitative assessment and comparable sparsity to the other pipelines despite
having significantly fewer features (Fig. 3.7, 3.1). The DADA2 feature inference al-
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gorithm may be aggressively grouping lower abundance true sequences with higher
abundance sequences. As a result, the low abundance sequences are not present in
samples leading to increased sparsity and higher abundance unmixed- and titration-
specific features. Adjusting the DADA2 parameters, specifically the OMEGA A pa-
rameter in setDadaOpt. Along these lines, the DADA2 documentation states that
the default setting for OMEGA A is conservative to prevent false positives at the cost
of increasing false negatives [19].
False positive features provide an explanation for Mothur and QIIME pipelines
having lower proportion of unmixed- and titration-specific features not explained by
sampling but high sparsity (Fig. 3.7, 3.1). The statistical tests used to determine
if the specific features could be explained by sampling only considers feature abun-
dance. Therefore, the statistical test is not able to distinguish between true low
abundance unmixed- and titration-specific features and low abundance sequence
artifacts. Mothur and QIIME count tables have ten times and three times more
features compared to DADA2, respectively (Table 3.1). While microbial abundance
distributions are known to have long tails, it is likely that the observed sparsity
is an artifact of the 16S rRNA sequencing measurement process. Similarly, signif-
icantly more features than expected are commonly observed for mock community
benchmarking studies evaluating the QIIME and Mothur pipelines [51].
False positive features can be reduced, but not eliminated, using smaller ampli-
con and prevalence filtering. The 16S rRNA region sequenced in the study is larger
than the region the de-novo, and open clustering pipelines were initially developed
for, potentially explaining the higher than expected sparsity [51]. The larger region
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has a smaller overlap between the forward and reverse reads. As a result merging
of the forward and reverse reads did not allow for the sequence error correction
that occurs when a smaller amplicon is used. However, even when targeting smaller
regions of the 16S rRNA gene both the de-novo (Mothur) and open-reference clus-
tering (QIIME) pipelines produced count tables with significantly more features
than expected in evaluation studies using mock communities. Prevalence filtering is
used to exclude low abundance features, likely predominantly measurement artifacts
[20]. For example, a study exploring the microbial ecology of the Red-necked stint
Calidris ruficollis, a migratory shorebird, used a hard filter to validate their study
conclusions are not biases by false positive features. The study authors compared
results with and without prevalence filter ensuring that the study conclusions were
not biased by using the arbitrary filter or including the low abundant features [83].
3.5.2 Using Mixtures to Assess 16S rRNA Sequencing
Mixtures of environmental samples have previously been used to assess RNAseq
and microarray gene expression measurements. However, this is the first time mix-
tures have been used to assess microbiome measurement methods. Our mixture
dataset allowed us to develop novel methods for assessing marker-gene-survey com-
putational methods. Our quantitative assessment allowed for the characterization
of relative abundance values using a dataset with a larger number of features and
dynamic range compared to assessments using mock communities. As a result, we
were able to identify previously unknown feature specific biases. Based on our study
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results additional experiments can be performed to identify the cause of these biases
and develop appropriate methods to account for them. Based on our subject-specific
results observation, we recommend that studies based on stool samples seeking infer-
ences in a longitudinal series of multiple subjects carefully estimate bacterial DNA
proportions and adjust inferences accordingly. Additionally, our qualitative assess-
ment results, when combined with sparsity information provide a new method for
evaluating how well bioinformatic pipelines account for sequencing artifacts without
loss of true biological sequences.
There were also limitations using our mixture dataset. These limitations in-
cluded: Lack of agreement between the proportion of unmixed samples titrations
and the mixture design. The number of features used in the different analysis. These
limitations are described below along with recommendations for addressing them in
future studies.
Differences in the proportion of prokaryotic DNA in the samples used to gen-
erate the two-sample titrations series results in differences between the true mixture
proportions and mixture design. We attempted to account for differences in mixture
proportion from mixture design by estimating mixture proportions using sequence
data. Similar to how the proportion of mRNA in RNA samples used in a previ-
ous mixture study. We were able to use an assay targeting the 16S rRNA gene to
detect changes in the concentration of bacterial DNA across titration, but unable
to quantify the proportion of bacterial DNA in the unmixed samples using qPCR
data. Using the 16S sequencing data we inferred the proportion of bacterial DNA
from the POST sample in each titration. However, the uncertainty and accuracy of
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the inference method are not known resulting in an unaccounted for error source.
A better method for quantifying sample bacterial DNA proportion or using
samples with consistent proportions would increase the expected value and in-turn
error metric accuracy. Limitations in the prokaryotic DNA qPCR concentration
assay precision limit the suitability for use in mixture studies. Digital PCR provides
a more precise alternative to qPCR and is, therefore, a more appropriate method.
Alternatively using samples where the majority of the DNA is prokaryotic would
minimize this issue. Mixtures of environmental samples can also be used to assess
shotgun metagenomic methods as well. As shotgun metagenomics is not a targeted
approach, differences in the proportion of bacterial DNA in a sample would not
impact the assessment results in the same way as 16S rRNA marker-gene-surveys.
Using samples from a vaccine trial allowed for the use of a specific marker
with an expected response, E. coli, during methods development. However, the
high level of similarity between the unmixed samples resulted in a limited number
of features that could be used in the quantitative assessment results. Using more
diverse samples to generate mixtures would address this issue.
3.6 Conclusions
This two-sample-titration dataset can be used to evaluate and characterize
bioinformatic pipelines and clustering methods. The sequence dataset presented in
this study can be processed with any 16S bioinformatic pipeline. Our quantitative
and qualitative assessment can then be performed on the count table and the results
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compared to those obtained using the pipelines included in this study. The threee
pipelines we evaluated produced sets of features varying in total feature abundance,
number of features per samples, and total features. The objective of any pipeline
is to differentiate true biological sequences from artifacts of the measurement pro-
cess. In general based on our evaluation results we recommend using for DADA2 for
feature-level abundance analysis, e.g. differential abundance testing. While DADA2
performed poorly in our qualitative assessment, the pipeline had performed bet-
ter in the quantitative assessment compared to the other pipelines. Additionally,
the DADA2 poor qualitative assessment results due to false-negative features are
unlikely to negatively impact feature-level abundance analysis, though additional
research is needed to validate this claim. When determining which pipeline to
use for a study, users should consider whether minimizing false positives (DADA2)
or false negatives (Mothur) is more appropriate for their study objectives. When
a sequencing dataset is processed using DADA2, the user can be more confident
that an observed feature represents a member of the microbial community and not
a measurement artifact. Pipeline parameter optimization could address DADA2
false-negative issue. For the Mothur and QIIME pipelines, prevalence filtering will
reduce the number of false-positive features. Feature-level results for any 16S rRNA
marker-gene survey should be interpreted with care, as the biases responsible for
poor quantitative assessment are unknown. Addressing both of these issues requires






Assessing the impact of sequencing characteristics on 16S
rRNA marker-gene surveys beta-diversity analysis.
4.1 Abstract
Originally developed for macro-ecology, beta-diversity metrics are commonly
used to assess overall community similarity between microbiome samples. The ef-
fects of sequencing depth and error rates on beta diversity calculations have not
been thoroughly studied. In the following study, we evaluate the impact of sequence
characteristics on beta-diversity analyses, and how well they are handled by different
bioinformatic pipelines and normalization methods. We use a mixture dataset of
stool samples from five vaccine trial participants, collected before and after exposure
to a pathogen and mixed following a two-sample titration. The sequencing data were
processed using six bioinformatics pipelines, including sequence inference, de novo,
and reference based clustering approaches, along with nine normalization methods,
including standard rarefaction approaches and numeric normalization techniques.
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We assess (1) beta-diversity repeatability for PCR replicates across multiple se-
quencing libraries and runs, (2) the ability to differentiate groups of samples with
varying levels of similarity and (3) differences in beta-diversity between biological
and technical factors. The Mothur and DADA2 pipelines were more robust to se-
quencing errors compared to the other pipelines evaluated in the study. Out of the
normalization methods compared in the study we suggest using total sum scaling for
weighted metrics. Normalizing counts using rarefaction improved assessment results
for unweighted metrics. Furthermore, we found normalization methods developed
for microarray and RNA sequencing data, including trimmed mean of M values
(TMM) and relative log expression (RLE), may not be appropriate for marker-gene
survey beta-diversity analysis.
4.2 Introduction
Microbial communities are frequently characterized by targeting a marker-gene
of interest (e.g., the 16S rRNA gene) for PCR amplification and high-throughput
sequencing [34]. While these approaches have been successfully used to improve
our understanding of microbiota taxonomy and diversity, they are subject to bi-
ases that can significantly affect downstream analysis. Bioinformatic pipelines and
normalization methods reduce these biases, especially for beta-diversity calculations
comparing sample community structure [34, 49].
Bioinformatic pipelines reduce bias by removing sequencing artifacts, such
as single and multi-base pair variants, and chimeric sequences, from microbiome
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datasets. If not accounted for, these artifacts may incorrectly be attributed as
novel diversity in a sample. Bioinformatic pipelines also use clustering or sequence
inference techniques to group reads into biologically informative units. Standard
clustering methods include de novo clustering based on pairwise sequence similar-
ities [88] and closed reference clustering of reads against a reference database [29].
Open reference clustering is a combination of the two, first applying a closed ref-
erence approach, followed by de novo clustering of reads that did not map to a
reference [82]. Sequence inference methods use statistical models and algorithms
to group sequences independent of sequence similarity but based on the probability
that a lower abundant sequence is an artifact originating from more highly abun-
dant sequence, independent of sequence similarity [19, 1]. The resulting features,
operational taxonomic units (OTUs) for clustering methods and sequence variants
(SVs) for sequence inference methods, have different characteristics because the dif-
ferent methods vary in their ability to detect and remove errors while retaining true
biological sequences.
Rarefaction and numeric normalization methods account for differences in sam-
ple total abundances caused by uneven pooling of samples prior to sequencing, and
differences in sequencing run throughput. Rarifying abundance data traces its ori-
gins to macroecology, where counts for a unit (sample) are randomly subsampled to
a user-defined constant level [35]. Although there are concerns about its statistical
validity [62], rarefaction is currently the only normalization method for unweighted,
presence-absence based, beta-diversity metrics [102]. For weighted, abundance based
beta-diversity analyses, we can apply numeric normalization methods, such as total
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and cumulative sum scaling (TSS and CSS), where counts are divided by sample
total abundance (TSS) or by the cumulative abundance (CSS) for a defined per-
centile [72]. CSS is one of the few normalization methods developed specifically for
16S rRNA marker-gene survey data. Other normalization methods, including upper
quartile (UQ), trimmed mean of M values (TMM) and relative log expression [84,
58], were initially developed for normalizing RNAseq and microarray data. Many
studies have found these methods useful in normalizing marker-gene survey data for
differential abundance analysis, though it is unclear whether these techniques are
also suitable for beta-diversity analysis.
Beta-diversity is calculated using a variety of metrics that can be grouped
based on whether they account for phylogenetic distance and feature relative abun-
dance. The UniFrac metric was developed specifically for marker-gene survey data
and incorporates phylogenetic relatedness by comparing the branch lengths of fea-
tures that are unique to two communities [37]. Unweighted UniFrac uses presence-
absence information, whereas weighted UniFrac incorporates feature relative abun-
dance. Taxonomic metrics do not consider the relationship between features. The
Bray-Curtis and Jaccard dissimilarity indices are examples of weighted and un-
weighted taxonomic metrics respectively, as they do not consider the phylogenetic
relationship between features [13, 44]. Because these four groups of beta-diversity
metrics measure different community characteristics, they are not interchangeable
should be evaluated in a complementary manner to gain maximal insight into com-
munity differences [2].
Previous studies have evaluated different bioinformatics pipelines [92] and nor-
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malization methods [62, 102] on beta-diversity analysis. Yet, the ability of these
pipelines to account for sequence quality and coverage, and how this affects diver-
sity conclusions, remains unknown. Here, we use a novel dataset of stool samples
from vaccine trial participants, collected before and after exposure to the pathogen,
and mixed following a two-sample titration mixture design. We sequenced multiple
technical PCR replicates, allowing us to evaluate (1) beta-diversity PCR repeata-
bility, and the ability to (2) distinguish between groups of samples with varying
levels of similarity, and (3) identify differences in beta-diversity between individuals
and treatment. Furthermore, the data was reproduced from across four runs with
different sequencing error rates and library sizes, enabling assessment of how each
pipeline and method performs on datasets of varying quality.
4.3 Methods
Our assessment framework utilizes a dataset of DNA mixtures from five vaccine
trial participants described in Section 3.3.1. DNA was extracted from stool collected
from five individuals (subjects) before and after exposure to pathogenic Escherichia
coli (timepoints). The pre- and post-exposure DNA was mixed following a log2 two-
sample titration mixture design, resulting in a set of samples with varying levels of
similarity. The microbial community in the unmixed pre- and post-exposure sam-
ples and titrations were measured using 16S rRNA marker-gene sequencing. Four
technical replicates of each were generated during the 16S rRNA PCR amplification
process. Technical replicates of each PCR were sent to two independent laboratories
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(JHU and NIST) for sequencing (Fig. 4.1).
Sequencing libraries were prepared at the independent laboratories using the
same protocol (16S Metagenomic Sequencing Library Preparation, posted date 11/27/2013,
downloaded from https://support.illumina.com). Resulting libraries were se-
quenced twice at each laboratory, resulting in four sequence datasets with varying
sequence quality and library sizes. The first JHU run PhiX error rate was higher
than expected and the instrument was re-calibrated by the manufacturer, resulting
in improved quality scores for the second run. The first run at NIST generated
lower total throughput than expected, so the pool library for the second run was
re-optimized and generated a dataset with increased throughput and lower sample
to sample read count variability. No template controls were also sequenced for qual-
ity control and did not reveal any significant reagent contamination. Sequence data
characterization was performed using the savR [16] and ShortRead Bioconductor R
packages [63].
4.3.1 Bioinformatic Pipelines
Data from the four sequencing runs were processed using six bioinformatic
pipelines, including the QIIME open reference, closed reference, de novo, and Deblur
pipelines, as well as the Mothur de novo pipeline and DADA2 sequence inference
pipeline. The code used to run the bioinformatic pipelines is available at https:
//github.com/nate-d-olson/mgtst_pipelines/, on the multirun branch. Pre-
processing and feature detection methods vary by pipeline. The Mothur pipeline
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uses the OptiClust algorithm for de novo clustering [103]. Pre-processing includes
merging and quality filtering paired-end reads followed by aligning sequences to the
SILVA reference alignment [89]. Taxonomic classification was performed using the
RDP Bayesian classifier [101] implemented in Mothur. The phylogenetic tree was
constructed in Mothur using the clearcut algorithm [91]. Mothur version 1.39.3
(https://www.mothur.org) and SILVA release version 119 reference alignment and
RDP the mothur formatted version of the RDP 16S rRNA database release version
10 [26].
The DADA2 big data protocol for DADA2 versions 1.4 or later was followed (ht
tps://benjjneb.github.io/dada2/bigdata.html), except for read length trim-
ming parameters and primer trimming. Forward and reverse primers were trimmed
using cutadapt version 1.14 (https://cutadapt.readthedocs.io/en/stable/) [56].
The forward and reverse reads were trimmed to 260 and 200 bp respectively. Read
trimming positions were defined based on read quality score distributions, maximiz-
ing the overlap region between the forward and reverse read while minimizing the
inclusion of low-quality sequence data. The pipeline was run using DADA2 ver-
sion 1.6.0 [19] and formatted SILVA database version 128 trainset provided by the
DADA2 developers [17]. Taxonomic classification was performed using the DADA2
implementation of the RDP Bayesian classifier [101]. The phylogenetic tree was
generated following methods in [20] using the DECIPHER R package for multiple
sequence alignment [108] and the phangorn R package for tree construction [87].
The QIIME pipelines all used the same merged paired-end, quality filtered set
of sequences [21]. UCLUST alogrithm (version v1.2.22q) was used for clustering and
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taxonomic assignment against the Greengenes database version 13.8 97% similarity
OTUs [29, 59]. Phylogenetic trees were constructed using FastTree, and a multiple
sequence alignment generated using pyNAST and the Greengenes reference align-
ment [21, 78]. Both open and closed reference pipelines used the Greengenes 97%
similarity database for reference clustering. Additionally, sequence variants were
inferred from the QIIME merged and quality-filtered sequences using Deblur (ver-
sion 1.0.3) [1]. Phylogenetic tree construction methods used for the other QIIME
pipelines were also used for the Deblur pipeline.
4.3.2 Normalization Methods and Beta-Diversity Metrics
Normalization methods are used to account for between-sample differences in
feature total abundance. Rarefaction, subsampling counts without replacement to
an even abundance, is a commonly used normalization method in macro-ecology and
16S rRNA marker-gene surveys [35, 40]. We rarefied samples to four levels; 2000,
5000, and 10000 total reads per sample, and to the total abundance of the 15th
percentile. Rarefaction levels were selected based on values used in published studies
[98] and other comparison studies [102, 62]. Rarified count data were analyzed
using both weighted and unweighted beta-diversity metrics. Numeric normalization
methods include those previously developed for normalizing microarray and RNAseq
data, such as upper quartile (UQ), trimmed mean of M values (TMM), and relative
log expression [84, 58], and those that are commonly used to normalize 16S rRNA
marker-gene survey, such as cumulative sum scaling (CSS) [72] and total sum scaling
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(proportions, TSS). Numeric normalization methods were used for weighted metrics,
as they do not impact unweighted metric results.
Weighted and unweighted phylogenetic and taxonomic beta-diversity metrics
were compared. Beta-diversity metrics were calculated using phyloseq version 1.22.3
[61]. Weighted and unweighted UniFrac phylogenetic beta-diversity metrics were
calculated using the phyloseq implementation of FastUniFrac [61, 37]. For feature-
level beta-diversity assessment, the Bray-Curtis weighted, and Jaccard unweighted
metrics were used [13, 44].
4.3.3 Beta-Diversity Assessment
Standard linear models were used to test for significance using the R lm
function. Mixed effects models, used to take into account repeated measures,
were fit using the R lmer function in the lme4 package [6]. Model fit was eval-
uated based on model statistics, AIC, BIC, and logLik, as well as diagnostic plots.
Tukey Honest Significant Differences test was used for multiple comparison test-
ing using the TukeyHSD function. The source code for all analysis is available at
https://github.com/nate-d-olson/diversity_assessment.
4.3.3.1 PCR Repeatability
Beta-diversity repeatability was evaluated for the different pipelines across
sequencing runs. Here we define repeatability as the median beta diversity be-
tween PCR replicates. The unnormalized count data was used to characterize the
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baseline beta-diversity repeatability for the different pipeline and sequencing runs.
Linear models were used to quantify differences between pipelines and across the
four sequencing runs for the diversity metrics. Data from the first NIST sequencing
run (NIST1) were used to evaluate normalization method impact on PCR repli-
cate beta-diversity. To quantify normalization method impact, independent linear
models were fit for each pipeline and diversity metric.
4.3.3.2 Signal to Noise Ratio
Next, we evaluated the signal-to-noise ratio for the different pipelines across
sequencing runs by comparing pre-exposure samples to other samples in the titra-
tion series. Signal was measured as the median beta-diversity between samples
were compared (Fig. 4.1). Noise was measured as the median PCR replicate beta-
diversity within the compared samples. A weighted average of the signal-to-noise
ratio was calculated as the area under the curve (using the trapz function) of the
signal-to-noise ratio and the proportion of pre-exposure DNA in the sample being
compared [12]. Independent linear models were fit for each diversity metric to quan-
tify differences in the signal-to-noise ratio between sequencing runs and pipelines. A
mixed-effects linear model was then used to quantify normalization method impact
on the signal-to-noise ratio using data from NIST1 with subject as a random effect.
Independent mixed effects linear models were fit for each pipeline and diversity
metric.
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4.3.3.3 Biological v. Technical Variation
To quantify the contribution of biological and technical variability to total
variability the distribution of beta diversity metrics were compared between sub-
jects, within subject and between conditions (pre- and post-exposure), and different
types of technical replicates. A linear model was used to quantify differences in
beta diversity between biological and technical sources of variability. We then used
variation partitioning [11] to quantify technical and biological factor’s contribution
to the total observed variation. Variation partition was calculated using the Vegan
R package [66]. Distance-based redundancy analysis (dbRDA) was used to identify
significant sources of variation [66].
4.4 Results
We sequenced the bacterial communities in stool samples collected from five
vaccine trial participants before and after exposure to pathogenic E. coli (Fig. 4.1).
Mixture samples were generated by titrating pre- and post-exposure samples at dif-
ferent concentrations. Each sample was sequenced twice at two different laboratories
(JHU and NIST) for a total of four runs.
4.4.1 Dataset Characteristics
The four replicate sequencing runs were of variable sequence quality and depth
(Fig. 4.2). Sequencing error rates and base quality scores also varied by sequencing
run. JHU1 had higher PhiX error rates compared to all other runs, especially for the
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Figure 4.1: Two-sample titration dataset experimental design. The dataset con-
tained independent two-sample titration series from 5 vaccine trial participants
(subjects), resulting in 45 samples. PCRs were run on two 96 well plates with
each plate half containing one for each sample and three no template control
reactions. The four replicate PCR assays per sample resulted in 180 PCRs. The
PCR products were split into technical replicates and sequenced twice at two
different laboratories.
Table 4.1: Summary statistics for the different bioinformatic pipelines. No template
controls were excluded from summary statistic calculations. Sparsity is defined as the
proportion of 0’s in the count table. Features is the total number of OTUs (QIIME and
mothur) or SVs (DADA2), rows in the count table. Singletons is the total number of
features only observed once in a single sample. Total Abundance is the median and range
(minimum-maximum) per sample total feature abundance. Pass Rate is the median and
range for the proportion of reads not removed while processing a sample’s sequence data
through a bioinformatic pipeline.
Pipelines Features Singletons Samples Sparsity Total Abundance Pass Rate
dada 25247 99 768 0.991 52356 (141585-181) 0.76 (0.87-0.01)
mothur 38367 24490 765 0.992 13312 (42954-171) 0.2 (0.45-0.02)
q closed 6184 829 754 0.929 24938 (111765-1) 0.36 (0.73-0)
q deblur 3711 0 576 0.940 9135 (30423-4) 0.14 (0.24-0)
q denovo 180834 120599 766 0.994 26250 (118767-4) 0.37 (0.75-0)



























































Figure 4.2: Sequencing quality and sample total abundance variation for the four
sequencing runs used in this study. The same set of 192 PCRs were sequenced
in all four runs. Independent sequencing libraries were generated at the two
sequencing laboratories (JHU and NIST). (A) PhiX error rate relative to 16S
rRNA amplicon base position for the four sequencing runs. (B) Distribution of
mode read quality score by sequencing run. (C) Sequencing run total abundance
coefficient of variation estimate and 95% confidence interval calculated using a













































































































Figure 4.3: Rarefaction curves for the four sequencing runs (line color) by pipeline
(A-F). Rarefaction curves were calculated using the feature counts summed across
all samples by sequencing run. Rarefaction curves indicate how thoroughly a pop-
ulation is sampled. Curves show the relationship between the number of unique
features (y-axis) and sampling depth. Curves reaching an asymptote indicate the
population has been completely sampled. Shapes indicate the observed feature
diversity and sampling depth. Solid lines represent interpolated values obtained
by randomly subsampling the observed abundance data. Dashed lines indicate
extrapolated values predicted based on the observed count data and interpolated
values.
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reverse reads (Fig. 4.2A). Read base quality was lower for the reverse read than the
forward reads for all four sequencing runs (Fig. 4.2B). Sequence data from the two
NIST runs had higher quality scores than the data from JHU runs, except for JHU2
forward reads (Fig. 4.2B). Greater variability in sample feature total abundance
was observed on the first run at each laboratory (Fig. 4.2C).
Overall, sequences from JHU1 had lower read quality and higher variability
in total sample abundance. Sequences from NIST1 were of higher quality but also
exhibited greater variability in total sample abundance. Thus, by comparing the
JHU1 results to the higher quality, less variable NIST2 and JHU2 runs, we can
evaluate how well the bioinformatic pipelines handle low quality reads. Similarly,
we can use data from the NIST1 to determine how well normalization methods can
account for differences in total abundance between samples.
Samples from the different sequencing runs were processed using six differ-
ent bioinformatic pipelines. Four of the pipelines, including the QIIME de novo,
QIIME closed-reference, QIIME open-reference, Mothur de novo, utilize OTU clus-
tering methods, while the remaining two, QIIME Deblur and DADA2, use sequence
inference approaches. Aside from the four QIIME pipelines each pipeline employs
its own pre-processing, feature inference, and quality filtering methods. The four
QIIME pipelines used the same pre-processing methods. As a result, the features
and count tables generated by the pipelines exhibit different characteristics in terms
of the number of features, total abundance, number of singletons, the proportion of
sequences passing quality control (Table 4.1).
We generated rarefaction curves to assess feature diversity at multiple sam-
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pling depths for across the four sequencing runs (Fig. 4.3). Sequence inference
methods (DADA2 and Deblur) had lower overall feature diversity estimates and
their rarefaction curves reached an asymptote around the same level (Fig. 4.3A &
B), suggesting that sampling depth was sufficient to capture community diversity.
The JHU1 rarefaction curves at the origin for the QIIME pipelines was due to lim-
ited number of features, none for Deblur, were produced by the pipelines. DADA2
asymptotes, however, were inconsistent across sequencing runs, indicating artificial
plateaus for the lower throughput and lower quality runs (Fig. 4.3A). Rarefaction
curves for de novo, open-reference, and closed-reference methods did not reach an
asymptote (Fig. 4.3). The QIIME de novo pipeline had the greatest slope, suggest-
ing the highest rate of artifacts (Fig. 4.3E). This is most likely due to the fact that
the QIIME de novo pipeline does not filter out singletons (Table 4.1). Furthermore,
the Mothur rarefaction curves were consistent across sequencing runs, but the QI-
IME clustering pipelines rarefaction curves were influenced by both sequence quality
and library size (Fig. 4.3D-F).
4.4.2 PCR Repeatability
Next, we evaluated differences in beta-diversity between un-normalized PCR
replicates across sequencing runs and pipelines. PCR replicate beta-diversity varied
by diversity metric (Fig. 4.2). Beta-diversity was consistently higher for unweighted
compared to weighted metrics, and phylogenetic diversity metrics were lower than
















































Sequncing Run jhu1 jhu2 nist1 nist2
Figure 4.4: Distribution of mean pairwise PCR replicate beta-diversity by se-
quencing run and pipeline for un-normalized count data.
quality JHU1 run compared to the higher quality JHU2 run. This was true for the
QIIME clustering pipelines. However the Mothur and DADA2 mean PCR replicate
beta-diversity was consistent across the JHU runs, suggesting that these pipelines are
more robust to sequencing errors (Fig. 4.2). Conversely, with the highest number
of failed samples for the first JHU run, the Deblur pipeline was the least robust
to sequencing errors (Table 4.1). As expected JHU2 and NIST2, with high read
quality and lower total abundance variability, had comparable PCR replicates beta-
diversity. Additionlly, NIST1 had higher PCR replicate beta-diversity compared to
JHU2 and NIST2, which is attributed to higher total abundance vairiability.
Data from NIST1 was used to compare normalization methods ability to im-
prove beta-diversity repeatability. When comparing normalized to un-normalized
89















































































































































Figure 4.5: Impact of normalization method on mean weighted (A) and un-
weighted (B) PCR replicates beta-diversity, for the sequencing run with higher
quality and total abundance variability, NIST1. Data are presented as minimal-
ink boxplots, where points indicate median value, the gap between point and
lines the interquartile range, and lines the boxplot whiskers. Solid black lines
represent median value and dashed lines indicate the first and third quartiles of
the raw (un-normalized) mean pairwise distances between PCR replicates.
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PCR replicate beta-diversity, we observed that most normalization methods reduced
beta-diversity between PCR replicates (Fig. 4.5A). For a number of pipelines, TMM
and RLE normalization methods significantly lowered weighted PCR replicate beta-
diversity (Fig. 4.5A). For unweighted metrics (Fig. 4.5B), rarefying count data to
2000 total feature abundance resulted in the lowest beta-diversity between PCR
replicates. While rarefying counts to the total abundance of the 15th most abun-
dant sample (rareq15) tended to significantly increase PCR replciates beta-diversity.
Rarefaction to this level is also most susceptible to sample loss and should not be
used as it results in unnecessary loss of statistical power.
4.4.3 Signal to Noise
We further sought to identify which pipelines and normalization methods are
best able to pull out biological signals from background, technical noise. We cal-
culated a signal-to-noise ratio by dividing the beta-diversity between unmixed pre-
exposure samples and other samples in the titration series (signal) by PCR repli-
cate beta-diversity for the samples being compared. The signal-to-noise ratio for
unweighted metrics on un-normalized samples was around 1 for all pipelines and
sequencing runs (Fig. 4.6), indicating that the signal magnitude (biological differ-
ences) was equal to the noise (differences between PCR replicates). Using weighted
metrics, only DADA2 and Mothur ratios were consistently greater than 1, and these
pipelines had higher ratio differences for the JHU runs compared to NIST runs.











































Sequencing Run jhu1 jhu2 nist1 nist2
Figure 4.6: The weighted average signal to noise varied by pipeline, run, and
diversity metric. Points indicate the signal to noise for each individual with grey
lines representing the range of values for a pipeline and sequencing run. Dark
grey horizontal lines indicate a signal-to-noise ratio of 1.
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T Statistic <2 >2
Figure 4.7: Weighted average signal to noise ratio estimate and 95 CI for raw
and normalized count data for (A) weighted and (B) unweighted beta-diversity
metrics. Estimates were calculated using a mixed effects linear model using sub-
ject as random effect. The horizontal solid line is the unnormalized count signal
to noise estimate,S and horizontal dashed lines indicate 95 CI. The points and
line ranges indicate the model estimate and 95 CI for the different normalization
methods. 93
consistent with the PCR replicate beta-diversity results.
Normalizing count data should increase the signal-to-noise ratio; however,
most normalization methods did not have a significant for weighted metrics (Fig.
4.7A). One exception was TSS, which significantly increased the Bray-Curtis sig-
nal to noise ratio for the Mothur and DADA2 datasets. Rarefying counts to the
15th quantile resulted in significantly lower the weighted UniFrac and Bray-Curtis
signal-to-noise ratio for QIIME closed-reference and de novo pipelines. While RLE
and TMM improved PCR replicate beta-diversity, these normalization methods also
significantly lowered the weighted UniFrac beta-diversity for DADA2, Mothur, and
QIIME de novo pipelines. Rarefaction often increased the unweighted metric signal-
to-noise ratio (Fig. 4.7B), though the increase was only significant at lower subsam-
pling depths for DADA2 and Mothur pipelines.
4.4.4 Biological v. Technical Variation
Finally, we characterized how different pipelines and normalization methods
capture diversity differences between biological factors and technical replicates. As
expected, the mean diversity observed between biological factors was greater than
between technical replicates (Fig. 4.8). The magnitude of this difference, how-
ever, was greater for weighted than unweighted beta-diversity metrics and varied by
pipeline. Greater differences were observed with the DADA2, Mothur, and Deblur
pipelines, compared to the QIIME clustering approaches.
Variation partitioning was used to identify the amount of variation attributable
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Figure 4.8: Biological vs. Technical Variation, distribution in (A) weighted and
(B) unweighted beta-diversity between technical replicates and biological treat-
ments (subject and timepoint).
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feature seq_run subject titration
Figure 4.9: Impact of different normalization methods on biological and technical
sources of variatoin for different pipelines and beta-diversity metrics. y-axis is the
adjusted R2, indicating the proportion of variance explained by each biological
(subject and titration) and technical (seq run) variable. Normalized adjusted
R2 values greater than and less than unnormalized values indicated with upright
triangle and upsidedown triangles, respectively. Vertical lines indicate difference
















































Sequencing Run jhu1 jhu2 nist1 nist2
Figure 4.10: Principal coordinate analysis for TMM and TSS normalized (A)
DADA2 and (B) Mothur unmixed PRE samples for Bray-Curtis and Weighted
UniFrac distance metrics.
97
to subject, titration factor (unmixed pre-exposure and unmixed post-exposure), and
sequencing run. When a normalization method increases the variation in the data
(distance matrix) for a biological factor and decreases the variation for a techni-
cal factor, the beta-diversity between biological samples (i.e. different subjects) in-
creases and beta-diversity between technical replicates (i.e. PCR assays) decreases.
When beta-diversity between biological factors is equivalent to or smaller than beta-
diversity between technical factors the method is no longer able to distinguish be-
tween the biological samples. Therefore the expectation is that normalization meth-
ods should decrease variation attributed to technical factors with either no change
or increase the variation due to biological factors. Across all pipelines and diversity
metrics, the greatest amount of variation is often explained by subject, followed by
titration factor (Fig. 4.9). The variation partitioning results are consistent with
our observation of greater biological than technical variability. Sequencing run ac-
counts for a greater proportion of the explained variance in the unnormalized runs,
highlighting the overall importance of normalizing our datasets.
Effective normalization methods decrease technical noise in the data with-
out decreasing biological signal. For both weighted (Fig. 4.9A) and unweighted
(Fig. 4.9B) metrics, rarefaction normalization methods show increased proportion
of variation explained by biological factors and decreased the proportion of varia-
tion explained by technical artifacts. Numeric normalization methods were not as
effective, especially for the QIIME pipelines. RLE and TMM normalization consis-
tently increased technical variability and often decreased biological variability (Fig.
4.9A). Principal coordiante analysis plots for the unmixed pre-exposure samples are
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Table 4.2: Pipeline beta-diversity assessment summary. +/- were used to qualitatively
summarise performance of the six pipelines in for the three assessments.
Pipelines PCR Repeatability Signal-to-Noise Biological v. Technical
dada + + +
mothur + + +
q closed + - -
q deblur + - +
q denovo - - -
q open - - -
consistent with variation partitioning results (Fig. 4.10). For Mothur and DADA2
the technical replicates group more tightly when TSS is used to normalize count
data compared to when TMM.
4.5 Discussion
Sequence error rate and variation in library size are just two sequencing charac-
teristics that can negatively bias beta-diversity analyses [62]. Ideally, bioinformatic
pipelines can help differentiate true biological sequences from artifacts generated by
sequencing errors [19] and normalization methods, such as rarefaction and total sum
scaling, can adjust for differences in library size [72]. However, the efficacy of these
different pipelines and normalization techniques for microbiome datasets, and how
they affect study conclusions, are not well characterized. We compared the perfor-
mance of six bioinformatic pipelines and nine normalization methods on mixture
samples for four beta-diversity metrics, finding that these pipelines and methods
vary significantly in their ability to identify and correct these biases.
We utilized a novel two-sample titration dataset of DNA extracts from five
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participants in a vaccine trial. Individual titration series were generated for each
participant, where DNA collected before exposure to pathogenic E. coli were titrated
into DNA samples collected after exposure. These samples were processed with
multiple levels of technical replication, including 16S rRNA PCR assays, sequencing
libraries, and sequencing runs that were performed in duplicate at two independent
laboratories. Our framework assessed three components: (1) beta-diversity repeata-
bility of PCR replicates, (2) signal-to-noise analysis of the between to within-sample
beta diversity of titration sets, and (3) contribution of biological (subjects and ex-
posure status) and technical factors (PCR replicates, sequencing labs, and runs) to
beta-diversity. Pipeline performance for the three assessments are summarized in
Table 4.2.
When comparing PCR replicates for all sequencing runs, the QIIME de novo
pipeline had high UniFrac values, but low weighted UniFrac values. This is most
likely due to the high proportion of singletons generated (Table 4.1). A large num-
ber of singletons indicates that a pipeline is unable to group sequencing artifacts
with true biological sequences. Beta-diversity measures the relationship between
single sample diversity (alpha) and system diversity (gamma). Inflated alpha- and
gamma-diversity due to spurious features, as observed with QIIME de novo will
result in inflated beta-diversity, and spurious features have a low probablility of
being observed in both samples. The removal of singletons, a step included in
many workflows such as the QIIME open-reference pipeline, can address this bias.
Deflated alpha- and gamma-diversity, as observed with DADA2, due to grouping
low abundance features with high abundance features, can similarity result in in-
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flated beta-diversity when shared features are incorrectly grouped with non-shared
features. The differences we observed in weighted and unweighted Unifrac values
also emphasize the importance of assessing multiple beta-diversity metrics, as each
metric provides unique insight into community composition shifts. Normalization
methods generally improved beta-diversity repeatability, with the exception of rar-
efying data to 15th quantile, which resulted in higher beta-diversity between PCR
replicates, especially for QIIME pipelines, possibly due to large sample loss. Count
data normalized using TMM and RLE consistently had lower beta-diversity values
between PCR replicates compared to un-normalized count data.
The biological signal magnitude was equal to the technical noise for un-normalized
samples, highlighting the overall importance of normalization. Rarefaction methods
at lower subsampling depths generally increased the signal to noise ratio for un-
weighted metrics, especially for the DADA2 and Mothur pipelines. Unexpectedly,
most numeric normalization methods did not increase the signal-to-noise ratio for
weighted metrics, and TMM and RLE normalization methods, which showed the
greatest similarity between PCR replicates, decreased our ability to tease out the
true biological indicators.
We finally evaluated the impact of different sources of variability on pipeline
and normalization methods by comparing diversity between biological samples and
technical replicates. For most pipelines and beta diversity metrics, normalizing
the count data increased the difference in beta diversity between biological and
technical replicates (Fig. 4.5), indicating a greater ability to detect community
levels differences between treatment conditions. Some metrics, namely rarefying
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to the 15th quantile, RLE, and TMM, frequently reduced the differences in beta-
diversity between the biological to technical factors. Variation partitioning results
were consistent with this conclusion (Fig. 4.9).
This study highlights the importance of rigorous evaluation of computational
tools and datasets. While we utilized six commonly cited bioinformatics pipelines,
there are many different approaches and researchers should think critically about
which is most appropriate for their own dataset. We used default program parame-
ters in our analyses to make our findings generally applicable. However, we strongly
advise researchers to have a good understanding of each step in their chosen pipeline,
including what parameters are required and whether they should be changed to best
fit data of interest.
Furthermore, this study shows the importance of normalizing microbiome
count tables prior to beta-diversity analyses. As the microbiome field is relatively
young, many existing normalization approaches are adopted from methods created
for other applications. For instance, RLE and TMM normalization methods were
initially developed for normalizing microarray and RNAseq data, not marker-gene
sequence data. While these methods improve differential abundance analysis [62],
they may not appropriate for beta-diversity analysis.
4.6 Conclusions
The results presented in this study can be used to help determine appropriate
bioinformatic pipeline and normalization method for a marker-gene survey beta-
102
diversity analysis. The six pipelines evaluated in this study varied in their ability to
distinguish sequencing artifacts from true biological sequences and these differences
impacted the PCR replicate beta-diversity repeatability. Based on our study results
we found Mothur and DADA2 to be more robust to lower quality sequence datasets.
Optimizing QIIME preprocessing methods may increase pipeline robustness to lower
quality data. Additionally, the assessment presented here evaluated full bioinfor-
matic pipelines, including both pre-processing and feature inference methods. Us-
ing the same set of pre-processed sequence data would allow for an independent
evaluation of the feature inference methods. Overall, we recommend using Mothur
when processing 16S rRNA sequencing data for beta-diversity analysis. Mothur was
more robust to low-quality sequence data, had consistent rarefaction curves between
sequencing runs, and performed well in our assessment. Additionally, as 24,490 of
the 38,367 Mothur features were singletons, singleton removal will likely improve
the assessment results.
Normalization can improve PCR replicate repeatability, but sometimes at the
cost of decreasing the differences in beta-diversity for biological relative to technical
factors. Our results indicate normalization methods developed for gene expression
data analysis may not be appropriate for marker-gene survey beta-diversity analy-
sis. For weighted metrics, we recommend normalizing counts using TSS and CSS.
These normalization methods improved assessment results or had no effect relative
to unnormalized counts. Rarefying count data improved unweighted metric results
but higher rarefaction levels tended to perform worse than unnormalized data. Rar-
efying counts lowers statistical power and therefore, it is not advisable when other
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normalization methods are available [62]. As numeric normalization methods are
not applicable to unweighted metrics, rarefying counts is the recommended normal-
ization method. To reduce the risk of the random subsampling step biasing beta
diversity results bootstrap replicates can be used to validate results.
Bioinformatic pipelines combine multiple algorithms to convert raw sequence
data into a count table which is subsequently used to test biological hypotheses.
Algorithm choice and parameters can significantly impact pipeline results. The
pipelines compared in this study were optimized using mock communities and bench-
marked against other methods based on similarity in beta-diversity results [10].
The novel assessment framework and dataset presented here provides complemen-





An R package for working with 16S rRNA reference
databases and marker-gene survey feature data.
5.1 Abstract
We developed the metagenomeFeatures R Bioconductor package along with
annotation packages for the three primary 16S rRNA databases (Greengenes, RDP,
and SILVA) to facilitate working with 16S rRNA sequence databases and marker-
gene survey feature data. The metagenomeFeatures package defines two classes,
MgDb for working with 16S rRNA sequence databases, and mgFeatures for working
with marker-gene survey feature data. The associated annotation packages pro-
vide a consistent interface to the different 16S rRNA databases facilitating database
comparison and exploration. The mgFeatures represents a crucial step in the devel-






16S rRNA marker-gene surveys have significantly advanced our understanding
of the diversity and structure of prokaryotic communities present in ecosystems
including the human gut, open ocean, and even the international space station [53,
98, 41]. For a 16S rRNA marker-gene survey, the 16S rRNA gene is sequenced using
a targeted assay. The raw sequence data is processed using a bioinformatic pipeline
where the sequences are grouped into features, e.g., operational taxonomic units
(OTUs) or sequence variants (SVs), yielding a set of representative sequences [18,
7].
A critical step in 16S rRNA marker-gene surveys is comparing representative
sequences to a reference database for taxonomic classification or phylogenetic place-
ment [65]. There are numerous 16S rRNA reference databases of which Greengenes,
RDP, and SILVA are arguably the most commonly used [28, 26, 79, 59]. Addition-
ally, there are smaller system-specific databases such as HOMD for the human oral
microbiome [22, http://www.homd.org/] and soil reference database [24]. System-
specific databases can improve taxonomic assignments for microbial communities
not well represented in the major databases [85].
16S rRNA databases differ in the number and diversity of sequences, the tax-
onomic classification system, and the inclusion of intermediate ranks [5, Table 5.1].
Databases format their data differently and use sequence identification systems
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Table 5.1: 16S rRNA gene sequence databases with Bioconductor annotation packages
we developed.
Database Version Sequences Taxonomic System
Greengenes 13.5 1,262,986 NCBI
RDP 11.5 3,356,809 Bergeys
SILVA 128.1 1,922,213 Bergeys
unique to their database, challenging membership and composition comparisons.
For example, Yang, Wang, and Qian [110] used the SILVA database to evaluate
how different 16S rRNA variable regions impact phylogenetic analysis. Similarly,
Martinez-Porchas et al. [57] also used the SILVA database to evaluate sequence
similarity between 16S rRNA gene conserved regions. Differences in database for-
matting present a significant barrier to performing the same analysis using multiple
databases. Additionally, taxonomic assignments can be database-dependent, pro-
viding further justification for database comparisons [75]. To facilitate database
comparisons RNACentral (http://rnacentral.org/) a resource combining non-
coding RNA databases, provides unique identifiers for the sequences [96].
We developed the R package metagenomeFeatures for working with both 16S
rRNA gene database and marker-gene survey feature data. metagenomeFeatures
provides a common data structure for working with the 16S rRNA databases and
marker-gene survey feature data. Additionally, this package is the first step towards
the development of a common data structure for use in analyzing metagenomic and
marker-gene survey data using R packages such as phyloseq [60] and metagenomeSeq
[73].
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5.3 MgDb and mgFeatures Class Description
The metagenomeFeatures package defines two data structures , MgDb for work-
ing with 16S rRNA databases, and mgFeatures for working with marker-gene sur-
vey feature data. There are three types of relevant information for both MgDb and
mgFeatures class objects, (1) the sequences themselves, (2) sequence taxonomic lin-
eage, and (3) a phylogenetic tree representing the evolutionary relationship between
features. MgDb and mgFeatures data structures are both S4 object-oriented classes
with slots for taxonomic, sequence, phylogenetic, and metadata.
As the 16S rRNA databases contain hundreds of thousands to millions of
sequences, an SQLite database is used to store the taxonomic and sequence data.
Using an SQLite database prevents the user from loading the full database into
memory. The database connection is managed using the RSQLite R package [64]).
The taxonomic data are accessed using the dplyr and dbplyr packages [105, 107].
The DECIPHER package is used to format the sequence data as an SQLite database
[108]. The phylo class, defined in a APE R package, is used to define the tree slot
[70]. We developed Bioconductor annotation packages for commonly used databases,
Greengenes, RDP, and SILVA Table [26, 79, 28, Table 5.1]. Along with database
specific sequence identifiers, RNAcentral identifiers are included in the SQLite table
for inter-database comparisons.
mgFeatures-class is used for storing and working with marker-gene survey
feature data. Similar to the MgDb-class, the mgFeatures-class has four slots, for
taxonomy, sequences, phylogenetic tree, and metadata. As the number of features in
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a marker-gene survey dataset is significantly smaller than the number of sequences
in a reference database, mgFeatures-class uses common Bioconductor data struc-
tures, DataFrames and DNAStringSets to define the taxonomic and sequence slots
[69, 68]. Similar to MgDb-class, a phylo-class object is used to define the tree
slot. For both the MgDb and mgFeatures classes the tree slot is optional, and the
metadata are stored as a list.
5.4 Applications/ Vignettes
The metagenomeFeatures package includes a series of vignettes as example
use cases for the metagenomeFeatures package and associated reference database
annotation packages. (1) Retrieving sequence and phylogenetic data for OTUs from
closed-reference clustering. (2) Exploring the diversity of a taxonomic group of
interest.
The R command browseVignettes(“metagenomeFeatures”) provides a list of
vignettes associated with the package and vignette(“x”) is used to view specific
vignettes, where “x” is the vignette name.
To further demonstrate the utility of the package, the manuscript supplemen-
tal information uses metagenomeFeatures, greengenes13.5MgDb annotation package,
and DECIPHER to evaluate the potential for species-level taxonomic classification
using 16S rRNA V12 and V4 sequence data.
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5.5 Conclusions
The metagenomeFeatures package provides data structures and functions for
working with 16S rRNA databases and marker-gene survey feature data. The data
structure provided by the MgDb-class in conjunction with the shared sequence iden-
tifier system developed by RNACentral facilitates comparisons between 16S rRNA
databases. The mgFeatures-class provides the groundwork for the development of
a common data structure for working with metagenomic and marker-gene sequence
data in R which will increase interoperability between R packages developed for
working with metagenomic sequence data. Additionally, while the data structures
were developed for 16S rRNA gene sequence data they can be used for any marker-
gene sequence data without modification and can be extended to work with shotgun
metagenomic sequence data and databases.
5.6 Supplemental Material
Paenibacillus species resolution for 16S rRNA V12 and V4 regions.
5.6.1 Background
16S rRNA amplicon sequencing is commonly used for microbial community
characterization, including differential abundance analysis. A limitation to 16S
rRNA amplicon sequencing is a lack of taxonomic resolution, where organisms are
only identifiable to the genus or family level. We define taxonomic resolution as the
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ability to differentiate between groups within a taxonomic level, for example dif-
ferentiating between species within a genus. While similar to determining whether
a sequence represents a novel species, here we are only interested in determining
whether the 16S rRNA region of interest contains sufficient information for species-
level taxonomic assignment. Taxonomic resolution varies by clade and amplicon
regions. Though the extent to which taxonomic resolition varies is not well charac-
terized.
Here we demonstrate how metagenomeFeatures and the MgDb annotation pack-
ages can be used to characterize taxonomic resolution for a specific clade and ampli-
con region, specifically for the Paenibacillus genus and V12 and V4 regions. Orig-
inally classified under the Bacillus genus, a novel genus was formed based on the
16S rRNA gene similarity in the 1990s. Paenibacillus spp. are facultative anaerobic
bacteria present in a variety of environments including the soil, water, and can act
as opportunistic pathogens in humans [67]. Paenibacillus spp. will play an impor-
tant role in sustainable agricultural industries [36]. As such, appropriate speciation
is of interest. The V12 and V4 region were used as they represent two commonly
used amplicons for 16S rRNA marker-gene surveys. We will use the Greengenes
13.5 database, accessed using the greengenes13.5MgDb annotation package for our
analysis of the Paenibacillus genus. The Greengenes 13.5 database is used for demon-
stration purposes but the other MgDb annotation packages can also be used; RDP
11.5 - ribosomaldatabaseproject11.5MgDb or SILVA 128.1 - silva128.1MgDb.
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5.6.2 Required Packages
In addition to metagenomeFeatures and greengenes13.5MgDb the DECIPHER,
tidyverse, and ggpubr packages are also used in the following analysis. Our analysis
uses the DECIPHER package to extract the amplicon regions, perform multiple se-
quence alignment, and generate a pairwise sequence distance matrix [Wright2016-mo].
The tidyverse and ggpubr packages will be used to reformat the taxonomic and











5.6.3 Paenibacillus Sequence and Taxonomy Data
We first subset the Greeengenes 13.5 database using the mgDb select func-
tion. Then summarize the taxonomy data using functions from tidyverse package,
specifically dplyr, stringr and forcats functions for manipulating data.frames,






## Per genus count data
taxa_df <- paeni_16S$taxa %>%
## cleaning up species names
mutate(Species = if_else(Species == "s__",
"Unassigned", Species),
Species = str_replace(Species, "s__","")) %>%
group_by(Species) %>%
summarise(Count = n()) %>%
ungroup() %>%
mutate(Species = fct_reorder(Species, Count))
## Count info for text
total_otus <- sum(taxa_df$Count)
unassigned_idx <- taxa_df$Species == "Unassigned"
no_species_assignment <- taxa_df$Count[unassigned_idx]
For the Greengenes 13.5 database, there are a total of 2912 sequences classi-
fied as 15 species in the Genus Paenibacillus. The number of sequences assigned to
specific Paenibacillus species range from 199 Paenibacillus amylolyticus to 2 Paeni-
bacillus illinoisensis (Fig. 5.1). Sequences only classified to the genus level, “Unas-
signed”, is the most abundant group, 2308.
5.6.4 Taxonomic resolution
Next, we evaluate the 16S rRNA amplicon sequencing taxonomic resolution for
Paenibacillus species by comparing within and between species amplicon pairwise
distance for the V12 and V4 regions. To differentiate between species the pair-
wise distances for within-species amplicon sequences must be less than the between






































Figure 5.1: Number of sequences assigned to species in the genus Paenibacillus.
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tances between and within species must be greater than the sequencing error rate
to detect the difference. For our taxonomic resolution analysis, we used pattern
matching to extract the V12 and V4 regions of the 16S rRNA sequences. We then
generate a pairwise distance matrix for the two regions and compare the within and
between species pairwise distances.
For our in-silico PCR we will use the following PCR primers:
Region Direction Primer
V12 Forward 27F - AGAGTTTGATCATGGCTCAG
Reverse 336R - CACTGCTGCSYCCCGTAGGAGTCT
V4 Forward 515F - GTGCCAGCMGCCGCGGTAA
Reverse 806R - GGACTACHVGGGTWTCTAAT
5.6.4.1 V12
Extracting the V12 region from the database sequences, only sequences with
containing both forward and reverse primers are included in the analysis.
forward_primer <- "AGAGTTTGATCATGGCTCAG"
## reverse complementing reverse primer
reverse_primer <- DNAString("CACTGCTGCSYCCCGTAGGAGTCT") %>%
reverseComplement() %>%
as.character()
## Finding sequeces with forward primer
forward_match <- Biostrings::vmatchPattern(forward_primer,
subject = paeni_16S$seq,
max.mismatch = 2) %>%
as.list() %>% map_dfr(as.data.frame,.id = "seq_id")





fixed = FALSE) %>%
as.list() %>% map_dfr(as.data.frame,.id = "seq_id")
## sequences with both forward and reverse primers
seqs_to_use_ids <- intersect(forward_match$seq_id,
reverse_match$seq_id)
seqs_to_use <- names(paeni_16S$seq) %in% seqs_to_use_ids





## Finding left pattern: 100% internal, 0% flanking
##
## Finding right pattern: 100% internal, 0% flanking
##
## Time difference of 0.06 secs
## Excluding seqs with lenght 0
paeni_V12_seqs <- paeni_V12[[2]][width(paeni_V12[[2]]) != 0]
Generating a multiple sequence alignment using the AlignSeqs function in
the DECIPHER package.
v12_align <- AlignSeqs(paeni_V12[[2]], verbose = FALSE)
The resulting alignment can be viewed using the BrowseSeqs function in the
DECIPHER package.
BrowseSeqs(v12_align)
Generating pairwise distance matrix using the DistanceMatrix function in
the DECIPHER package for taxonomic resolution analysis and converting distance






v12_dist_df <- v12_dist %>%
as.data.frame() %>%
rownames_to_column(var = "Keys") %>%
gather("Keys2","distance", -Keys) %>%
mutate(Keys = as.numeric(Keys),
Keys2 = as.numeric(Keys2)) %>%
filter(Keys < Keys2) %>%
mutate(Keys = as.character(Keys),
Keys2 = as.character(Keys2))
tax_df <- dplyr::select(paeni_16S$taxa, "Keys", "Species")
v12_dist_anno_df <- v12_dist_df %>%
left_join(tax_df) %>%
left_join(tax_df,by = c("Keys2" = "Keys")) %>%
dplyr::rename(Keys_Species = Species.x,
Keys2_Species = Species.y) %>%
mutate(group_comp = if_else(Keys_Species == Keys2_Species,
"within","between")) %>%
filter(Keys_Species != "s__", Keys2_Species != "s__")
5.6.4.2 V4
For the V4 region, we will use the same approach, extract amplicon region, fil-
ter extracted sequences based on amplicon length, generate pairwise distance matrix
using a multiple sequence alignment, and then evaluate pairwise distances.
## Finding sequeces with forward primer
forward_match <- Biostrings::vmatchPattern("GTGCCAGCMGCCGCGGTAA",
subject = paeni_16S$seq,
fixed = FALSE) %>%
as.list() %>% map_dfr(as.data.frame,.id = "seq_id")
## Finding sequences with reverse primer
reverse_match <- Biostrings::vmatchPattern("ATTAGAWACCCBDGTAGTCC",
subject = paeni_16S$seq,
fixed = FALSE) %>%
as.list() %>% map_dfr(as.data.frame,.id = "seq_id")
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## sequences with both forward and reverse primers
seqs_to_use_ids <- intersect(forward_match$seq_id,
reverse_match$seq_id)
seqs_to_use <- names(paeni_16S$seq) %in% seqs_to_use_ids





## Finding left pattern: 100% internal, 0% flanking
##
## Finding right pattern: 100% internal, 0% flanking
##
## Time difference of 0.81 secs
## Excluding seqs with lenght 0
paeni_V4_seqs <- paeni_V4[[2]][width(paeni_V4[[2]]) != 0]
### Calculate distance matrix from multiple sequence alignment





## Creating a data frame for exploratory analysis
v4_dist_df <- v4_dist %>%
as.data.frame() %>%
rownames_to_column(var = "Keys") %>%
gather("Keys2","distance", -Keys) %>%
mutate(Keys = as.numeric(Keys), Keys2 = as.numeric(Keys2)) %>%
filter(Keys < Keys2) %>%
mutate(Keys = as.character(Keys), Keys2 = as.character(Keys2))
tax_df <- dplyr::select(paeni_16S$taxa, "Keys", "Species")
v4_dist_anno_df <- v4_dist_df %>%
left_join(tax_df) %>%
left_join(tax_df,by = c("Keys2" = "Keys")) %>%
dplyr::rename(Keys_Species = Species.x,
Keys2_Species = Species.y) %>%
mutate(group_comp = if_else(Keys_Species == Keys2_Species,
"within","between")) %>%
filter(Keys_Species != "s__", Keys2_Species != "s__")




























Figure 5.2: Primer trimmed sequence, amplicon, length and start and end posi-
tions relative to full length sequences for the V12 and V4 regions.
## - mean pairwise distance to all other




5.6.4.3 Amplicon Sequence Lengths
The trimmed sequence length varies for forward and reverse primers resulting
in varying amplicon sizes for both the V12 and V4 amplicons (Fig. 5.2).
Genus Level Comparison Pairwise distance is significantly different for within and
between species comparisons indicating that the V12 and V4 regions are potentially
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V12 V4










Species Comparison between within
Figure 5.3: Distribution of within and between species pairwise distances for the
V4 16S rRNA region. Sequences not classified to the species level were excluded
from the analysis.
suitable forclassifying members of the Paenibacillus genus to the species level (Fig.
5.3). Overall the V12 region had greater pairwise distances than V4 for both within
and between species. It is important also to consider that the majority of sequences
in the database were only classified to the genus level. Species-level information for
these sequences might yield results that are inconsistent with our analysis. Addi-
tionally, our analysis does not identify the pairwise sequence distance required to
classify a sequence as a novel Paenibacillus species.
Species level comparison While the overall pairwise distance is greater between
species than within species for the Paenibacillus genus, it is important to under-
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stand how the within and between species pairwise distances compare for individual
species. The heatmap below shows pairwise distance information for within and be-
tween different Paenibacillus species for the V12 and V4 regions (Fig. 5.4). Whether
the sequences are assigned to more than one OTU depends on the pairwise sequence
distance metric and linkage method employed by the clustering algorithm. In gen-
eral though for species levels classification the maximum within species distance
should be less than the minimum between species distance. For example as the
maximum within species pairwise distance for P. lentimorbus is 0.13 and the mini-
mum between species pairwise distance for P. lentimorbus and P. alvei is 0.08 (Fig.
5.4A), correctly assigning a V12 amplicon sequences to one of these two species is
not possible.
5.6.5 Conclusion
Here we demonstrate how the metagenomeFeatures package in conjunction
with one of the associated 16S rRNA database packages, greengenes13.5MgDb, and
other R packages, can be used to evaluate whether species-level taxonomic clas-
sification is possible for a specific amplicon region. The approach used here can
easily be extended to use different 16S rRNA databases (starting with a different
MgDbclass object), taxonomic groups (changing filtering parameters), or amplicon



































































































































































































































































































































































































































































Figure 5.4: Pairwise distances between Paenibacillus species (A) V12 and (B)
V4 amplicon regions. Fill color indicates the mean pairwise sequence distance
within and between species. The text indicates the maximum pairwise distance
for within-species comparisons, values along the diagonal, and maximum pair-
wise distance for between species comparisons. Different number of species are
included in the V12 and V4 plots as there are no full-length P. chondroitinus




For this dissertation, I developed a framework for assessing the 16S rRNA
marker-gene survey measurement process. The framework utilizes novel statistical
methods in conjunction with an assessment dataset specifically developed for this
dissertation. I created mixtures of human gut microbiome samples and sequenced
them in multiple laboratories and runs. Based on this experimental design I defined
multiple measurement assessment metrics. The statistical methods assess 16S rRNA
marker-gene survey relative abundance, differential abundance, and beta diversity
using information from the unmixed samples and mixture design. The mixture
dataset was a two-sample titration series of vaccine trial DNA extracts. Additionally,
I developed the R Bioconductor package, metagenomeFeatures for working with 16S
rRNA reference databases and marker-gene survey feature data.
The metagenomeFeatures package provides data structures and functions for
working with 16S rRNA gene sequence reference databases and marker-gene survey
feature data. The data structure provided by the MgDb-class in conjunction with
the shared sequence identifier system developed by RNACentral facilitates compar-
isons between 16S rRNA databases. The mgFeatures-class provides the ground-
work for the development of a common data structure for working with metagenomic
and marker-gene sequence data in R which will increase interoperability between R
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packages developed for working with metagenomic sequence data. Additionally,
while the data structures were developed for 16S rRNA gene sequence data they
can be used for any marker-gene sequence data without modification and can be
extended to work with shotgun metagenomic sequence data and databases.
Based on lessons learned from this dissertation, new mixture datasets can be
developed for further microbiome measurement assessment. Additional 16S rRNA
sequencing mixture datasets would serve as a complementary resource for the com-
munity. Using samples with either better characterized prokaryotic DNA propor-
tions, or minimal non-prokaryotic DNA, would reduce the expected value uncer-
tainty observed in this assessment. Also, using samples with larger differences in
microbial composition as titration endpoints to generate the mixtures would provide
a more extensive set of features for assessment. As the mixtures were only processed
using a single laboratory protocol (16S PCR through sequencing), mixture samples
can be used as part of an interlaboratory study to further characterize the mea-
surement process repeatability and reproducibility. Finally, mixtures can be used
to assess other microbiome measurement processes such as shotgun metagenomics,
metatranscriptomics, and even non-nucleic acid measurements such as metapro-
teomics and metametabolomics.
The work presented here has shown how a mixture dataset can be used to as-
sess the marker-gene survey measurement process. Using the assessment framework,
I evaluated 16S rRNA marker-gene survey bioinformatic pipeline and normalization
performance. Bioinformatic pipelines combine multiple algorithms converting raw
sequence data into count tables which are subsequently used to test biological hy-
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potheses. Algorithm choice and parameters can significantly impact pipeline results.
The pipelines compared in this dissertation were optimized using mock communi-
ties and benchmarked against other methods based on similarity in beta-diversity
results [10]. The assessment framework and dataset provide complementary methods
for use in optimizing existing and benchmarking new pipelines and normalization
methods. The mixture dataset can be processed with any bioinformatic pipeline
that converts raw 16S rRNA sequencing data to a count table. The relative and
differential abundance, as well as beta-diversity assessment, can be performed on the
count table and the results compared to those obtained with the pipelines evaluated
in this dissertation. Future work includes the development of an R Bioconductor
package for employing our assessment framework, metagenomeAssessment.
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